This is a Validated Antibody Database (VAD) review about mouse Cd8b1, based on 625 published articles (read how Labome selects the articles), using Cd8b1 antibody in all methods. It is aimed to help Labome visitors find the most suited Cd8b1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cd8b1 synonym: Cd8b; Ly-3; Ly-C; Lyt-3

Invitrogen
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4b
Invitrogen Cd8b1 antibody (Invitrogen, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4b). Nat Commun (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:5000; loading ...; fig 6b
Invitrogen Cd8b1 antibody (Ebioscience, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:5000 (fig 6b). Cancers (Basel) (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3c
Invitrogen Cd8b1 antibody (Invitrogen, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:200 (fig 3c). Cancers (Basel) (2021) ncbi
rat monoclonal (4SM15)
  • immunocytochemistry; mouse; 1:100; fig 3b
Invitrogen Cd8b1 antibody (Thermo Fisher Scientific, 4?C0808) was used in immunocytochemistry on mouse samples at 1:100 (fig 3b). J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen Cd8b1 antibody (eBioscience, 25-0081-82) was used in flow cytometry on mouse samples (fig 3d). Cell Death Dis (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; loading ...; fig 4d
Invitrogen Cd8b1 antibody (eBioscience, 11-0081-85) was used in flow cytometry on mouse samples at 1:50 (fig 4d). Cells (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 7e
Invitrogen Cd8b1 antibody (Invitrogen, 14-0808-80) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7e). NPJ Breast Cancer (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; fig 7e
Invitrogen Cd8b1 antibody (Thermo fisher, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 7e). Cell Rep (2021) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; 1:400; loading ...
Invitrogen Cd8b1 antibody (eBioscience, 25-0083-80) was used in flow cytometry on mouse samples at 1:400. Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; 1:100; fig 2e
Invitrogen Cd8b1 antibody (eBioscience, 14-0081-82) was used in immunohistochemistry on mouse samples at 1:100 (fig 2e). Cell Death Discov (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen Cd8b1 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2e
Invitrogen Cd8b1 antibody (Invitrogen, 14-0081-82) was used in immunohistochemistry - frozen section on mouse samples (fig 2e). Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen Cd8b1 antibody (Thermo Fisher Scientific, 48-0081-82) was used in flow cytometry on mouse samples at 1:100. elife (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; 1:40; loading ...
Invitrogen Cd8b1 antibody (ThermoFisher Scientific, 53-0081-82) was used in flow cytometry on human samples at 1:40. elife (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3f
Invitrogen Cd8b1 antibody (Ebiosciences, 14-0808-80) was used in immunohistochemistry - paraffin section on mouse samples (fig 3f). Mol Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen Cd8b1 antibody (eBioscience, 12-0081-81) was used in flow cytometry on mouse samples (fig 2b). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; tbl 2
Invitrogen Cd8b1 antibody (Thermo Fisher, 47-0081-82) was used in flow cytometry on mouse samples (tbl 2). Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 6c
Invitrogen Cd8b1 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig 6c). Cell Prolif (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen Cd8b1 antibody (eBioscience, 56-0081-82) was used in flow cytometry on mouse samples . Mucosal Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen Cd8b1 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig s3). Cell Death Dis (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). BMC Res Notes (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6c). Antioxidants (Basel) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen Cd8b1 antibody (Thermo-Fisher, 12-0081-82) was used in flow cytometry on mouse samples . J Exp Clin Cancer Res (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 7e
Invitrogen Cd8b1 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7e). Nat Commun (2021) ncbi
rat monoclonal (5H10)
  • flow cytometry; human; loading ...; fig 5f
Invitrogen Cd8b1 antibody (Thermo Fisher, MCD0801) was used in flow cytometry on human samples (fig 5f). Oncogene (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 7
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 7). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Mucosal Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen Cd8b1 antibody (eBioscience, 13-0081-82) was used in flow cytometry on mouse samples (fig s2b). Cell (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4
Invitrogen Cd8b1 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig s4). Eur J Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen Cd8b1 antibody (Thermo Fisher, 53-0081-82) was used in flow cytometry on mouse samples (fig 4c). Cell (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a, s1b
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1a, s1b). BMC Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; fig 4a
Invitrogen Cd8b1 antibody (eBioscience, 16-0081-81) was used in immunohistochemistry on mouse samples (fig 4a). Basic Res Cardiol (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4b
Invitrogen Cd8b1 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 4b). Cell (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 5e
Invitrogen Cd8b1 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:50 (fig 5e). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; 1:100; loading ...; fig 6a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on human samples at 1:100 (fig 6a). Front Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7b
Invitrogen Cd8b1 antibody (Invitrogen, 53-6.7) was used in flow cytometry on mouse samples (fig 7b). PLoS Pathog (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig 4d
Invitrogen Cd8b1 antibody (Invitrogen, 17-0081-82) was used in flow cytometry on mouse samples at 1:300 (fig 4d). Cell Res (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3, s4
Invitrogen Cd8b1 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig 3, s4). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2e
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2e). Nature (2020) ncbi
rat monoclonal (4SM16)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6e
Invitrogen Cd8b1 antibody (eBioscience, 14-0195-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 6e). Sci Transl Med (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen Cd8b1 antibody (eBioscience, 53.6-7) was used in flow cytometry on mouse samples . elife (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5b
Invitrogen Cd8b1 antibody (Fisher Scientific, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig 5b). Cancers (Basel) (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5b
Invitrogen Cd8b1 antibody (eBioscience, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig 5b). Acta Neuropathol (2020) ncbi
rat monoclonal (KT15)
  • flow cytometry; mouse; 1:100; loading ...; fig s15
Invitrogen Cd8b1 antibody (ThermoFisher, MA5-16761) was used in flow cytometry on mouse samples at 1:100 (fig s15). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5b
Invitrogen Cd8b1 antibody (eBioscience, 12-0081-82) was used in flow cytometry on mouse samples (fig 5b). Aging (Albany NY) (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; loading ...; fig s5a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:50 (fig s5a). Mol Ther Methods Clin Dev (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:800; fig s15b
Invitrogen Cd8b1 antibody (Thermo Fisher, 12-0081-81) was used in flow cytometry on mouse samples at 1:800 (fig s15b). Nat Commun (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - frozen section; mouse; 1:150; loading ...; fig 2a
Invitrogen Cd8b1 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - frozen section on mouse samples at 1:150 (fig 2a). Nat Commun (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s7f
Invitrogen Cd8b1 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples (fig s7f). Nature (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d, s3a, s3b
Invitrogen Cd8b1 antibody (ThermoFisher, 47-0081-82) was used in flow cytometry on mouse samples (fig 2d, s3a, s3b). Cell Rep (2019) ncbi
rat monoclonal (4SM16)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4f
Invitrogen Cd8b1 antibody (Thermo Fisher, 4SM16) was used in immunohistochemistry - paraffin section on mouse samples (fig 4f). Cell Rep (2019) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; 1:400; fig s1g
Invitrogen Cd8b1 antibody (Thermo Fisher, eBioH35-17.2) was used in flow cytometry on mouse samples at 1:400 (fig s1g). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 5b
Invitrogen Cd8b1 antibody (eBioscience, MA1-10304) was used in flow cytometry on mouse samples at 1:100 (fig 5b). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s1f
Invitrogen Cd8b1 antibody (Invitrogen, 11-0081-85) was used in flow cytometry on mouse samples at 1:200 (fig s1f). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s4
Invitrogen Cd8b1 antibody (eBioscience, 17-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig s4). Nature (2019) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Cd8b1 antibody (eBioscience, 11-0083-85) was used in flow cytometry on mouse samples (fig 3a). Science (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3a, s3b
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s3a, s3b). Sci Adv (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3s1
Invitrogen Cd8b1 antibody (eBiosciences, 25-0081-81) was used in flow cytometry on mouse samples at 1:100 (fig 3s1). elife (2019) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; loading ...; fig s1d
Invitrogen Cd8b1 antibody (Thermo Fisher, 5H10) was used in flow cytometry on mouse samples (fig s1d). Science (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 5a
Invitrogen Cd8b1 antibody (eBioscience, 14-C0808) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5a). Br J Cancer (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2c
Invitrogen Cd8b1 antibody (eBioscience, 25-0081-82) was used in flow cytometry on mouse samples (fig s2c). Cell (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:4000; loading ...; fig 5a
Invitrogen Cd8b1 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:4000 (fig 5a). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2h, 3k, 5a
Invitrogen Cd8b1 antibody (Ebioscience, 45-0081-82) was used in flow cytometry on mouse samples (fig 2h, 3k, 5a). Oncoimmunology (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Cd8b1 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Science (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3f
Invitrogen Cd8b1 antibody (ebioscience, 14-0808-80) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3f). JCI Insight (2019) ncbi
rat monoclonal (53-6.7)
  • other; mouse; loading ...; fig 2b
Invitrogen Cd8b1 antibody (eBioscience, 13-0081-86) was used in other on mouse samples (fig 2b). Int Immunol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig s5a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig s5a). Science (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; fig 6a
Invitrogen Cd8b1 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a). Cancer Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig e3b
Invitrogen Cd8b1 antibody (Invitrogen, 47-0081-82) was used in flow cytometry on mouse samples at 1:200 (fig e3b). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:2000; loading ...; fig e5c
Invitrogen Cd8b1 antibody (eBioscience, 17-0081-83) was used in flow cytometry on mouse samples at 1:2000 (fig e5c). Nature (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7e
Invitrogen Cd8b1 antibody (eBioscience, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig 7e). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e3p
Invitrogen Cd8b1 antibody (eBioscience, 56-0081-82) was used in flow cytometry on mouse samples (fig e3p). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s6a
Invitrogen Cd8b1 antibody (eBioscience, 12-0081-82) was used in flow cytometry on mouse samples (fig s6a). Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2d). J Exp Med (2019) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; loading ...; fig s7c
Invitrogen Cd8b1 antibody (Invitrogen, MCD0830) was used in flow cytometry on mouse samples (fig s7c). Cell Metab (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Cd8b1 antibody (Thermo Fisher Scientific, A15386) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). Oncoimmunology (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 5a
Invitrogen Cd8b1 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples at 1:1000 (fig 5a). Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Immune Netw (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4b
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4b). Front Immunol (2018) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; loading ...; fig 4c, 5c
Invitrogen Cd8b1 antibody (eBioscience, eBioH35-17.2) was used in flow cytometry on mouse samples (fig 4c, 5c). Int J Cancer (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2d
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 2d). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5d). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Cd8b1 antibody (eBioscience, 56-0081-82) was used in flow cytometry on mouse samples (fig 3b). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; mouse; loading ...; fig 1c
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in immunocytochemistry on mouse samples (fig 1c). Science (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4
Invitrogen Cd8b1 antibody (eBioscience, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig s4). JCI Insight (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s2a, s2b
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s2a, s2b). J Pathol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2d
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 2d). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd8b1 antibody (eBioscience, 12-0081-81) was used in flow cytometry on mouse samples (fig 1a). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Cd8b1 antibody (eBioscience, 53-C6.7) was used in flow cytometry on mouse samples (fig 3b). PLoS ONE (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s3b
Invitrogen Cd8b1 antibody (eBioscience, 25-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig s3b). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1a). Blood (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig ev2c
Invitrogen Cd8b1 antibody (eBioscience, 53?\6.7) was used in flow cytometry on mouse samples (fig ev2c). EMBO J (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4i
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4i). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Sci Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s3c
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig s3c). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3b
Invitrogen Cd8b1 antibody (eBiosciences, 53.6.7) was used in flow cytometry on mouse samples (fig s3b). Science (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Cd8b1 antibody (Thermo Fisher Scientific, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Eur J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2c
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 2c). PLoS ONE (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig 3c
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:300 (fig 3c). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 4a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 4a). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; loading ...; fig s11c
Invitrogen Cd8b1 antibody (Thermo Fisher Scientific, 47-0081-82) was used in flow cytometry on mouse samples at 1:500 (fig s11c). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5k
  • immunohistochemistry; mouse; loading ...; fig 4d
Invitrogen Cd8b1 antibody (eBioscience, 14-0081-82) was used in flow cytometry on mouse samples (fig 5k) and in immunohistochemistry on mouse samples (fig 4d). Cancer Res (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen Cd8b1 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples (fig 2b). Cell Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e2c
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig e2c). Nature (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1e
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s1e). Cell Stem Cell (2018) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:40; loading ...; fig 5a
Invitrogen Cd8b1 antibody (Thermo Fisher, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:40 (fig 5a). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4d
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4d). EMBO J (2018) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; fig 5c
Invitrogen Cd8b1 antibody (eBioscience, 14-0808) was used in immunohistochemistry - paraffin section on mouse samples (fig 5c). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig s3d
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in immunohistochemistry on mouse samples (fig s3d). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3e). J Virol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Cd8b1 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). Oncogene (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2b). Cell Metab (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c
Invitrogen Cd8b1 antibody (Affymetrix/eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 1c). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Cd8b1 antibody (Thermo Fisher Scientific, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1a). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig s14a
Invitrogen Cd8b1 antibody (eBioscience, 25-0081) was used in flow cytometry on human samples (fig s14a). Nat Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). Front Immunol (2018) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; fig 1f
Invitrogen Cd8b1 antibody (eBiosciences, 11-0083-82) was used in flow cytometry on mouse samples (fig 1f). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; loading ...; fig s4b
Invitrogen Cd8b1 antibody (eBiosciences, 17-0081-82) was used in flow cytometry on mouse samples at 1:500 (fig s4b). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3b
Invitrogen Cd8b1 antibody (eBiosciences, 56-0081-82) was used in flow cytometry on mouse samples (fig 3b). Cell (2018) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; fig s2d
Invitrogen Cd8b1 antibody (eBiosciences, 11-0083-85) was used in flow cytometry on mouse samples (fig s2d). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2d). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Science (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 7a). Cell (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2e
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2e). Cancer Res (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...
Invitrogen Cd8b1 antibody (ebioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400. Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3c
In order to investigate the effect of polymicrobial sepsis in skin immune response, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3c). PLoS Pathog (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Cd8b1 antibody (eBioscience, 53.6-72) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, Invitrogen Cd8b1 antibody (eBioscience, 12-0081-83) was used in flow cytometry on mouse samples (fig 1b). Cell Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the involvement of Sec22b in antigen cross-presentation and antitumor immunity, Invitrogen Cd8b1 antibody (eBiosciences, 45-0081-82) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to investigate the role of type I interferons in diet-induced obesity and insulin resistance, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Diabetologia (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to characterize murine monocytes through transcriptome and genome analyses, Invitrogen Cd8b1 antibody (eBioscience, 17-0081-82) was used in flow cytometry on mouse samples (fig 5a). Immunity (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s6g
In order to study the role of reprogrammed BCAA metabolism in the progression of myeloid leukaemia, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s6g). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen Cd8b1 antibody (eBiosciences, 12-0081-81) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1.4b
In order to investigate the generation of macrophage populations during homeostasis and inflammation, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s1.4b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2c
In order to investigate the function of AIM2 inflammasome in influenza-iInduced lung injury and mortality, Invitrogen Cd8b1 antibody (Thermo, 25-0081-81) was used in flow cytometry on mouse samples (fig s2c). J Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
In order to study the effects of IL-10R signaling during Plasmodium berghei ANKA-induced experimental cerebral malaria, Invitrogen Cd8b1 antibody (eBiosciences, 53.6-7) was used in flow cytometry on mouse samples (fig s1a). Infect Immun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1b
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, Invitrogen Cd8b1 antibody (Thermo Fisher Scientific, 53?C6.7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • other; mouse; fig s2a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in other on mouse samples (fig s2a). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2c
In order to demonstrate that type 1 T helper cells play a crucial role in vessel normalization, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2c). Nature (2017) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 5e
Invitrogen Cd8b1 antibody (eBiosciences, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 5e). JCI Insight (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...
In order to show that Eros is essential for host defense via the phagocyte NAPDH oxidase, Invitrogen Cd8b1 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:400. J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 8a
In order to determine the role of RelB in classical dendritic cell and myeloid development, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 8a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4h
In order to examine the relationships among the B cell receptor, TLR9, and cytokine signals that regulate B cell responses to DNA-containing antigens, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4h). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5b
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5b). Nat Commun (2017) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; loading ...; fig s7b
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen Cd8b1 antibody (eBioscience, 4SM15) was used in immunohistochemistry on mouse samples (fig s7b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3d
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen Cd8b1 antibody (eBioscience, 48-0081-82) was used in flow cytometry on mouse samples (fig s3d). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c,d
In order to examine the contribution of stroma-derived osteopontin for hematopoietic stem cell aging, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c,d). EMBO J (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to study anti-cancer immunity after Treg depletion in mice., Invitrogen Cd8b1 antibody (ebioscience, 47?\0081?\82) was used in flow cytometry on mouse samples (fig 1b). Immun Inflamm Dis (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to explore the role of Nol3 in myeloproliferative neoplasms, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). J Exp Med (2017) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; loading ...; fig S4
In order to study a mouse model of anti-human PD-L1 for developing new cancer treatments., Invitrogen Cd8b1 antibody (eBioscience, eBioH35-17.2) was used in flow cytometry on mouse samples (fig S4). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig 6c
In order to examine two llama-derived single-domain respiratory syncytial virus neutralizing antibodies, Invitrogen Cd8b1 antibody (eBioscience, 25-0081-81) was used in flow cytometry on mouse samples at 1:300 (fig 6c). Nat Commun (2017) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; 1:400; loading ...; fig 1b
In order to evaluate the use of a recombinant Newcastle disease virus expressing ICOS ligand to treat cancer, Invitrogen Cd8b1 antibody (eBioscience, 46-0083) was used in flow cytometry on mouse samples at 1:400 (fig 1b). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4i
In order to determine the contribution of B cell to obesity-induced insulin resistance, Invitrogen Cd8b1 antibody (eBiosciences, 12-0081-81) was used in flow cytometry on mouse samples (fig 4i). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1d
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen Cd8b1 antibody (eBioscience, 25-0081) was used in flow cytometry on mouse samples (fig 1d). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s6a
In order to show a role for Hippo signaling in the epicardium in recruiting T regulatory cells post infarct, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s6a). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Blood (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2c). Cell Mol Life Sci (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to test if MSI2 modulates FLT3 expression, Invitrogen Cd8b1 antibody (ebioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2c). Leuk Res (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2a
In order to test if intraperitoneal administration of adeno-associated virus produces unique patterns of tissue tropism, Invitrogen Cd8b1 antibody (eBioscience, 14-0081-82) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2a). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
In order to establish a method to isolate apoptotic bodies from cultured cells to 99% purity, Invitrogen Cd8b1 antibody (eBioscience, 12-0081-82) was used in flow cytometry on mouse samples (fig 2d). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
In order to utilize a G2-Gata4Cre;R26REYFP mouse line to track the developmental fate of the G2-Gata4 cell lineage, Invitrogen Cd8b1 antibody (EBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Haematologica (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1g
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1g). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to assess the role of p38 signaling in limiting regulatory T cell induction, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Biol Chem (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to explore if the anti-diabetic sulphonylurea glibenclamide protects insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3c
In order to discuss how NLRC3 protects against colorectal cancer by modulating mTor signaling, Invitrogen Cd8b1 antibody (Affymetrix eBioscience, 48-0081-82) was used in flow cytometry on mouse samples (fig s3c). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to study the role of T cells in the effector phase of antibody-mediated autoimmune dermatoses, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2016) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd8b1 antibody (eBioscience, H35-17.2) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to explore how antigen-dependent pathways modulate skin-resident memory T cell generation, Invitrogen Cd8b1 antibody (eBioscience, 53.6.7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2j
In order to characterize Nlrp2-deficient mice and identify a role for this protein in fertility, Invitrogen Cd8b1 antibody (eBioscience, 17-0081-81) was used in flow cytometry on mouse samples (fig 2j). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5e
In order to investigate strains of Listeria monocytogenes that activate necrosis, apoptosis, or pyroptosis and study the role of CD8 positive T cells in these processes, Invitrogen Cd8b1 antibody (ebioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5e). Infect Immun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5a
In order to study CD153+ PD-1+ CD44hi CD4+ T cells in the visceral adipose tissue of high fat diet-fed obese mice, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s5a). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to find that dendritic cells modulate thymic egress, Invitrogen Cd8b1 antibody (ebioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4b). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:800; loading ...; fig 4d
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:800 (fig 4d). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6a
In order to determine the impact of myeloperoxidase during malaria infection, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 6a). Infect Immun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2a
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 2a). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3h
In order to study the role of miR-7 in acute lung injury, Invitrogen Cd8b1 antibody (ebioscience, 25-0081-81) was used in flow cytometry on mouse samples (fig 3h). Front Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
In order to identify and characterize a Nei endonuclease VIII-like 3 mutation in three siblings from a consanguineous family with autoimmunity, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). J Clin Invest (2016) ncbi
rat monoclonal (YTS105.18)
  • blocking or activating experiments; mouse; fig 9b
In order to propose that blocking antibodies suppress autoreactive CD8 positive T-cell activation in a relatively selective manner, Invitrogen Cd8b1 antibody (Thermo Scientific, YTS105.18) was used in blocking or activating experiments on mouse samples (fig 9b). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2B
In order to examine the thymic microenvironment using a model of paracoccidioidomycosis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2B). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . Mucosal Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3
Invitrogen Cd8b1 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (KT15)
  • flow cytometry; mouse; loading ...; fig 8a
In order to characterize the immunological changes in tumors induced by radiation therapy, Invitrogen Cd8b1 antibody (Thermo Fisher Scientific, KT15) was used in flow cytometry on mouse samples (fig 8a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3b
In order to develop and characterize a murine model of hepatitis A virus, Invitrogen Cd8b1 antibody (eBiosciences, 14-0808) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3b). Science (2016) ncbi
rat monoclonal (53-6.7)
  • western blot; mouse; 1:1000; fig 4
Invitrogen Cd8b1 antibody (eBioscience, 14-0081) was used in western blot on mouse samples at 1:1000 (fig 4). Sci Rep (2016) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
In order to establish and characterize a mouse model of narcolepsy, Invitrogen Cd8b1 antibody (eBioscience, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5a
Invitrogen Cd8b1 antibody (Affymetrix eBioscience, 25-0081-82) was used in flow cytometry on mouse samples (fig 5a). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd8b1 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples (fig 4). Front Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen Cd8b1 antibody (Ebioscience, 12-0081) was used in flow cytometry on mouse samples (fig 5). BMC Complement Altern Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1d
In order to identify Matrilin-4 (Matn4) as a negative regulator of the hematopoietic stem cell stress response, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; fig s4k
In order to investigate the effects of caloric restriction on beige fat, Invitrogen Cd8b1 antibody (eBioscience, 12-0081) was used in flow cytometry on mouse samples at 1:200 (fig s4k). Cell Metab (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3a
  • flow cytometry; mouse; fig s2
In order to measure expression of major histocompatibility complex class one and paired immunoglobulin-like receptor B in the central and peripheral nervous system after sciatic nerve injury in mice, Invitrogen Cd8b1 antibody (eBioscience, 11-0081) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3a) and in flow cytometry on mouse samples (fig s2). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1d
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 8
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 8). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). PLoS Pathog (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
In order to implement lck-cre transgenic mice to study the role of loxP-targeted genes in T cell development and function, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5c
In order to examine the role of BRPF1 during hematopoiesis, Invitrogen Cd8b1 antibody (eBiosciences, 11-0081-81) was used in flow cytometry on mouse samples (fig s5c). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
In order to demonstrate that lymphotoxin beta receptor directly controls thymic endothelial cells to guide hematopoietic progenitor cell homing, Invitrogen Cd8b1 antibody (eBioscience, 47-0081) was used in flow cytometry on mouse samples (fig s1a). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
In order to investigate the roles of platelets and patrolling Ly6C low monocytes in acute vascular inflammation, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; loading ...; fig 1a
In order to demonstrate that Blimp-1 controls CD4 T cell exhaustion, Invitrogen Cd8b1 antibody (Affymetrix eBioscience, H35-17.2) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6). Clin Cancer Res (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to determine the role of Id3 in germinal center B cells, Invitrogen Cd8b1 antibody (BD Pharmingen or eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Mol Cell Biol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1d
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3
In order to report that vaccine-induced T regulatory cells aid to control de novo primed autoreactive effector CD8(+) T cells in a diabetes model, Invitrogen Cd8b1 antibody (BD Biosciences, 17-0081-83) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • immunohistochemistry; mouse; 1:75; loading ...; fig 3e
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, Invitrogen Cd8b1 antibody (eBioscience, 14-0083) was used in immunohistochemistry on mouse samples at 1:75 (fig 3e). Gut (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to investigate the role of general control non-derepressible 2 in resolving autoimmune neuroinflammation, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Neuroimmunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 11-0081) was used in flow cytometry on mouse samples . Front Cell Neurosci (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1-s1
In order to propose that the ERK-AP-1 axis is important for translating TCR signal strength into proportional activation of downstream events, Invitrogen Cd8b1 antibody (eBiosciences, 13-0081-86) was used in flow cytometry on mouse samples (fig 1-s1). elife (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, Invitrogen Cd8b1 antibody (eBioscience, 45-0081-8) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2016) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; 1:200; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, Invitrogen Cd8b1 antibody (Invitrogen, MCD0817) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; fig st1
Invitrogen Cd8b1 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples at 1:500 (fig st1). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig st2
In order to identify the origin of vascular smooth muscle cells and macrophages within atherosclerosis lesions, Invitrogen Cd8b1 antibody (eBioscience, 25-0081) was used in flow cytometry on mouse samples (fig st2). Atherosclerosis (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to discuss Staphylococcus aureus-derived allergens, Invitrogen Cd8b1 antibody (eBioscience, 45-0081-80) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1a
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). elife (2016) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; loading ...; fig s1a
In order to examine the dynamics of anti-inflammatory T cells in the intestine, Invitrogen Cd8b1 antibody (eBioscience, H35-17.2) was used in flow cytometry on mouse samples (fig s1a). Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1b
In order to examine the dynamics of anti-inflammatory T cells in the intestine, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1b). Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to detail how to obtain innate lymphoid cells from isolated common lymphoid progenitors, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . Bio Protoc (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3g
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3g). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s4
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:66; loading ...; fig 2f
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen Cd8b1 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:66 (fig 2f). Nat Cell Biol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). Cell Biosci (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
In order to discover cell-intrinsic division and differentiation differences in neonatal CD8+ T cells, Invitrogen Cd8b1 antibody (eBiosciences, 48-0081-82) was used in flow cytometry on mouse samples (fig 2). Immunol Cell Biol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; fig s3
In order to characterize dysregulation of neuronal network activity following a stroke due to microglia protecting against brain injury and their selective elimination, Invitrogen Cd8b1 antibody (eBioscience, 12-0081-82) was used in flow cytometry on mouse samples at 1:400 (fig s3). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s6
In order to investigate the effects of IL-1 on hematopoietic stem cells, Invitrogen Cd8b1 antibody (eBioscience, 16-0081-82) was used in flow cytometry on mouse samples (fig s6). Nat Cell Biol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 48-0081) was used in flow cytometry on mouse samples . Biol Open (2016) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; mouse; fig 1
Invitrogen Cd8b1 antibody (eBioscience, 13-0081-85) was used in immunocytochemistry on mouse samples (fig 1). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4b
In order to assess whether flagellin is useful as an adjuvant for a topical therapeutic vaccine for female genital cancer, Invitrogen Cd8b1 antibody (eBioscience, 55-3030) was used in flow cytometry on mouse samples (fig 4b). Oncoimmunology (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s4
Invitrogen Cd8b1 antibody (eBioscience, 11-0081) was used in flow cytometry on mouse samples at 1:100 (fig s4). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd8b1 antibody (eBioscience, 53-C6.7) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
Invitrogen Cd8b1 antibody (eBioscience, 48-0081-82) was used in flow cytometry on mouse samples (fig 2). Mucosal Immunol (2017) ncbi
rat monoclonal (2.43)
  • immunohistochemistry - paraffin section; mouse; 1:25-1:50; fig 4
In order to study how Tg6F ameliorates the increase in oxidized phosopholipids in mice jejunum that were fed unsaturated LysoPC or WD diets, Invitrogen Cd8b1 antibody (Thermo Scientific, MA1-145) was used in immunohistochemistry - paraffin section on mouse samples at 1:25-1:50 (fig 4). J Lipid Res (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 4b
In order to show that FMNL1 regulates podosomes and normal macrophage migration, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 4b). Cellbio (Irvine, Calif) (2015) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 10
Invitrogen Cd8b1 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 10). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen Cd8b1 antibody (eBioscience, 53.6.7) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). Infect Immun (2016) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • blocking or activating experiments; mouse; loading ...; fig 3
In order to discuss models of squamous lung tumors to test therapeutic regimens, Invitrogen Cd8b1 antibody (e-Bioscience, H35-17.2) was used in blocking or activating experiments on mouse samples (fig 3). J Thorac Oncol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s21
Invitrogen Cd8b1 antibody (eBioscience, 17-0081-82) was used in flow cytometry on mouse samples (fig s21). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s6a
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s6a). Nat Commun (2016) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse
In order to elucidate the mechanisms by which fetal-type hemoglobin is repressed, Invitrogen Cd8b1 antibody (eBioscience, eBio-H35-17.2) was used in flow cytometry on mouse samples . Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3). PLoS Pathog (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to test if enforced virus replication occurs in the presence of virus-specific antibodies or virus-specific CD8 positive T cells, Invitrogen Cd8b1 antibody (eBioscience, 53?C6.7) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to show that ATP11C is an aminophospholipid translocase in immune cells, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 11-0081-85) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6). PLoS Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2J
In order to determine that Th2 cell responses, alternative macrophage activation, and immunoglobulin class switching to IgG1, are enhanced in Batf3(-/-) mice responding to helminth parasites, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2J). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; mouse
Invitrogen Cd8b1 antibody (eBioscience, 11-0081-82) was used in immunohistochemistry - paraffin section on mouse samples . Nature (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to research the connection between oligodendrocyte death and immune-mediated CNS demyelination, Invitrogen Cd8b1 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples (fig 4). Nat Neurosci (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 3
In order to determine the affects of dendritic cell migration in vitro by loss of gadkin, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; fig s8
In order to test if GATA5 is a regulator of blood pressure, Invitrogen Cd8b1 antibody (eBioscience, 17-0081-81) was used in flow cytometry on mouse samples at 1:1000 (fig s8). Nat Commun (2015) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; fig 2
Invitrogen Cd8b1 antibody (eBioscience, eBioH35-17.2) was used in flow cytometry on mouse samples (fig 2). J Immunol (2016) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to explore the impact of chronic antigenic stimulation on CD4(+) T cell dynamics, Invitrogen Cd8b1 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3
In order to determine how induced arthritis can be effectively treated by CTRP6, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s3). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to investigate the role of FAT10 in thymic antigen presentation, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to determine the role of Syk in development of obliterative bronchiolitis, Invitrogen Cd8b1 antibody (EBioscience, 53-6.7) was used in flow cytometry on mouse samples . Am J Transplant (2016) ncbi
rat monoclonal (YTS 169AG 101HL)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 2
In order to study transplantation of pancreatic tissue in TheraCyte encapsulation devices that is protected and prevents hyperglycemia in an mouse model of immune-mediated diabetes, Invitrogen Cd8b1 antibody (Pierce Antibodies, MA1-70041) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2). Cell Transplant (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Science (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4b
In order to test if anti-retroviral natural killer cell functions are inhibited by T regulatory cells during an acute Friend retrovirus infection, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4b). Retrovirology (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Cancer Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 46-0081-80) was used in flow cytometry on mouse samples . J Vis Exp (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to evaluate as a mucosal vaccine platform against influenza A virus, Invitrogen Cd8b1 antibody (eBioscience, # 11-0081-82) was used in flow cytometry on mouse samples (fig 5). Front Immunol (2015) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, Invitrogen Cd8b1 antibody (Invitrogen, 5H-10) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to test if metformin ameliorates ionizing radiation-induced long-term bone marrow injury in a total-body irradiation mouse model, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Free Radic Biol Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Immunity (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to optimize application routes for trifunctional bispecific antibodies against tumor-associated ganglioside GD2, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Mol Cancer Ther (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; human; fig s8
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, Invitrogen Cd8b1 antibody (ebiosciences, 53.67) was used in immunohistochemistry - paraffin section on human samples (fig s8). Nat Biotechnol (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; fig 6
Invitrogen Cd8b1 antibody (eBiosciences, 14008182) was used in immunohistochemistry on mouse samples (fig 6). Oncotarget (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6e
  • immunohistochemistry; mouse; loading ...; fig 4k
In order to find that lymph node-like vasculature in melanoma and lung carcinoma murine models is both a consequence of and key contributor to anti-tumor immunity, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6e) and in immunohistochemistry on mouse samples (fig 4k). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
Invitrogen Cd8b1 antibody (eBioscience, 55-6.7) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 25-0081-82) was used in flow cytometry on mouse samples . Cardiovasc Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; fig 2
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:1000 (fig 2). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen Cd8b1 antibody (eBioscience, 15-0081-82) was used in flow cytometry on mouse samples (fig 5). PLoS Negl Trop Dis (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen Cd8b1 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples (fig 5). EMBO Mol Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6b
  • immunohistochemistry; mouse; loading ...; fig 3a
In order to determine if specific B cell subsets or if B cell-derived interleukin-10 contributes to tolerance, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6b) and in immunohistochemistry on mouse samples (fig 3a). Transplantation (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1). PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3A
In order to report a B cell-intrinsic role for Rab7, Invitrogen Cd8b1 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples (fig 3A). J Immunol (2015) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; fig s2
Invitrogen Cd8b1 antibody (eBioscience, eBioH35-17.2) was used in flow cytometry on mouse samples (fig s2). Nat Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 2
In order to test if carbon monoxide suppresses chronic inflammation and leads to metabolic disturbances, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 2). Am J Physiol Endocrinol Metab (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl s3
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2
In order to elucidate the function of miR-29a in hematopoietic stem and progenitor cells, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s2). Blood (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
In order to test if blocking several checkpoint receptors boosts anti-tumor immunity in a low-dose, lymphodepleting whole body radiation model, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). J Immunother Cancer (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
  • immunocytochemistry; mouse; fig 2
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1) and in immunocytochemistry on mouse samples (fig 2). J Exp Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Immunol Cell Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on human samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 3
Invitrogen Cd8b1 antibody (eBioscience, 15-0081) was used in flow cytometry on mouse samples at 1:100 (fig 3). Biol Reprod (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to show how early events during viral infection decide the immune response and facilitate either control, clearance, or persistence of the virus, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to identify Cd8 cis-regulatory elements, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse
In order to identify Cd8 cis-regulatory elements, Invitrogen Cd8b1 antibody (eBioscience, H35-17.2) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
  • immunocytochemistry; mouse
Invitrogen Cd8b1 antibody (eBioscience or BioLegend, 53-6.7) was used in flow cytometry on mouse samples and in immunocytochemistry on mouse samples . Cell Mol Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • immunohistochemistry - frozen section; mouse; fig 1
Invitrogen Cd8b1 antibody (eBioscience, clone H35-17.2) was used in immunohistochemistry - frozen section on mouse samples (fig 1). Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Development (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . J Am Heart Assoc (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5i
In order to investigate the application of intra-dermal mesoporous silica rods in immune modulation., Invitrogen Cd8b1 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples (fig 5i). Nat Biotechnol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
  • immunocytochemistry; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples and in immunocytochemistry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3
Invitrogen Cd8b1 antibody (ebioscience, 53.67) was used in flow cytometry on mouse samples (fig s3). J Natl Cancer Inst (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
Invitrogen Cd8b1 antibody (eBioscience, 53-6.8) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to examine the role of lymph node stromal cells in immune responses, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . elife (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . EMBO J (2014) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, H35-17.2) was used in flow cytometry on mouse samples . EMBO J (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study CD4 and CD8 responses to L. monocytogenes using GZMB-Tom knock-in mice, Invitrogen Cd8b1 antibody (eBioscience, 53.6.7 A700) was used in flow cytometry on mouse samples . Immunology (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1b
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). Nat Immunol (2014) ncbi
rat monoclonal (KT15)
  • immunohistochemistry - paraffin section; human
In order to study the effects of IL9 in multiple models of breast and colon cancer development using IL-9 KO mice, Invitrogen Cd8b1 antibody (Thermo Scientific, MA5-16761) was used in immunohistochemistry - paraffin section on human samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig S2a
In order to investigate the role of DUSP6 in colonic CD4 positive T-cell function, differentiation, and inflammatory profile, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig S2a). Mucosal Immunol (2015) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (BD Biosciences, MCD0830) was used in flow cytometry on mouse samples . J Neuroimmunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Nat Med (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:50
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples at 1:50. Mol Pharm (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3c
In order to test the efficacy of combining different monoclonal antibodies to treat cancer, Invitrogen Cd8b1 antibody (ebioscience, 14-0081-82) was used in flow cytometry on mouse samples (fig 3c). Clin Cancer Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to investigate the use of mannosylated synthetic long peptides for vaccination, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to assess the contribution of Tbx1 to thymus and parathyroid development, Invitrogen Cd8b1 antibody (eBioscience, clone 53-6.) was used in flow cytometry on mouse samples . Development (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to show that MID1 regulates cytotoxic lymphocytes responses, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s5
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s5). Mucosal Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to examine the quantitative and temporal requirements of Zap70's function in thymocyte development, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Nat Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2014) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to determine if HSPs ameliorate ischemic renal injury in vivo using HSF-1 KO mice, Invitrogen Cd8b1 antibody (Invitrogen, MCD0830) was used in flow cytometry on mouse samples . Kidney Int (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience Inc., 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; 1:50
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in immunohistochemistry on mouse samples at 1:50. PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Bone (2014) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; human; tbl 2
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in immunocytochemistry on human samples (tbl 2). J Clin Invest (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
In order to study the involvement of endothelium in efficient Treg T cell recruitment in vivo, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to investigate the effects of lymphopenia and chronic exposure to IFN on T cell homeostasis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5a). PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
Invitrogen Cd8b1 antibody (Ebioscience, 12-008-81) was used in flow cytometry on mouse samples (fig s1). PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to characterize the Treg populations the Friend retrovirus mouse model, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Virol Sin (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50
Invitrogen Cd8b1 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples at 1:50. Acta Neuropathol Commun (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
Invitrogen Cd8b1 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:100. Cell Transplant (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to characterize tumor-associated macrophages isolated from gastrointestinal stromal tumors, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3). J Exp Med (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse
Invitrogen Cd8b1 antibody (ebioscience, 53-6.7) was used in immunohistochemistry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine optimal IL-17-inducing conditions using a vaccine and Mycobacterium tuberculosis challenge strategy, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Surg Infect (Larchmt) (2014) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 3
In order to examine Treg cell control of chronic autoimmunity in a lymphoreplete host, Invitrogen Cd8b1 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig 3). J Immunol (2013) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; fig 2
In order to elucidate the role of dendritic cells in cancer immunosurveillance failure, Invitrogen Cd8b1 antibody (eBioscience, H35-17.2) was used in flow cytometry on mouse samples (fig 2). Immunol Cell Biol (2013) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of dendritic cells in cancer immunosurveillance failure, Invitrogen Cd8b1 antibody (Caltag, CT-CD8) was used in flow cytometry on mouse samples (fig 2). Immunol Cell Biol (2013) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of dendritic cells in cancer immunosurveillance failure, Invitrogen Cd8b1 antibody (Caltag, CT-CD8) was used in flow cytometry on mouse samples (fig 2). Immunol Cell Biol (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of CD4+ T cells in Porphyromonas gingivalis infection, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Mol Oral Microbiol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Stem Cells (2014) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to characterize mice deficient in podoplanin and explore the effect of podoplanin modulation on T cell populations, Invitrogen Cd8b1 antibody (CALTAG, 5H10) was used in flow cytometry on mouse samples (fig 2). Immunol Lett (2013) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; 1:200; fig 9
Invitrogen Cd8b1 antibody (eBioscience, 12-0083-83) was used in flow cytometry on mouse samples at 1:200 (fig 9). PLoS ONE (2013) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig 4b
In order to assess different ways to use rotaviral V6 as a vaccine candidate, Invitrogen Cd8b1 antibody (eBioscience, 16-0081) was used in blocking or activating experiments on mouse samples (fig 4b). Hum Vaccin Immunother (2013) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 2
In order to determine if Bok and Bax have any functional redundancy controlling apoptosis using knock out mice, Invitrogen Cd8b1 antibody (Caltag, clone YTS169) was used in flow cytometry on mouse samples (fig 2). Cell Death Dis (2013) ncbi
rat monoclonal (YTS 169AG 101HL)
  • flow cytometry; mouse; fig 2
In order to determine if Bok and Bax have any functional redundancy controlling apoptosis using knock out mice, Invitrogen Cd8b1 antibody (Caltag, clone YTS169) was used in flow cytometry on mouse samples (fig 2). Cell Death Dis (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 5b
In order to report the development of dendritic cells and other lineages in Bcl11a knockout mice, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 5b). PLoS ONE (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to test if a differential composition of immune cells within the central nervous system modulates the age-associated susceptibility to autoimmune disease, Invitrogen Cd8b1 antibody (Invitrogen, MCD0830) was used in flow cytometry on mouse samples (fig 1). J Neuroinflammation (2013) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; tbl 2
In order to use poly(I:C)-injected dams to study the effects of inflammation on fetal development, Invitrogen Cd8b1 antibody (Invitrogen, CT-CD8b) was used in flow cytometry on mouse samples (tbl 2). Brain Behav Immun (2013) ncbi
rat monoclonal (YTS 169AG 101HL)
  • immunohistochemistry - paraffin section; mouse; 1:50
  • immunohistochemistry; mouse; 1:50
In order to study the ability of adenosine A2A receptor activation to inhibit epithelial-mesenchymal transition and the development of renal interstitial fibrosis in a murine model, Invitrogen Cd8b1 antibody (Pierce, MA1-70041) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 and in immunohistochemistry on mouse samples at 1:50. PLoS ONE (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to report that interferon gamma is essential for effective ionizing radiation therapy, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Am J Pathol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to review the role of S1P lyase in T cell-mediated disease, Invitrogen Cd8b1 antibody (ebioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to study immune exhaustion, Invitrogen Cd8b1 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig 2). J Exp Med (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl 1
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (tbl 1). PLoS ONE (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBiosciences, 17-0081) was used in flow cytometry on mouse samples . PLoS Genet (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study heterogeneous clonal T cell responses, Invitrogen Cd8b1 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples . J Immunol (2013) ncbi
rat monoclonal (53-6.7)
  • other; mouse; fig 5
  • flow cytometry; mouse; fig 5
In order to study the impact of mesenchymal stem cells to experimental allergic encephalomyelitis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in other on mouse samples (fig 5) and in flow cytometry on mouse samples (fig 5). Front Immunol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . FASEB J (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 4
In order to discuss the use of synthetic vaccines employing synthetic mRNA to treat cancer, Invitrogen Cd8b1 antibody (Invitrogen, MCD0801) was used in flow cytometry on mouse samples (fig 4). Methods Mol Biol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (2013) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 5a
In order to report that CD81 interacts with the T cell receptor to suppress signaling, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 5a). PLoS ONE (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1b
In order to quantify the CD8 T cells needed to cause type 1 diabetes and observe the anatomy of the CD8 T cell/beta cell interaction at the immunologic synapse, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). PLoS Pathog (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to report that ABCG1 regulates iNKT cell development in a cell-intrinsic manner, Invitrogen Cd8b1 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig 2). J Immunol (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the role of BTB-ZF factors in lymphoid effector programs, Invitrogen Cd8b1 antibody (e-Bioscience, 53-6.7) was used in flow cytometry on mouse samples . Nature (2012) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study the kinetics of iNKT cell precursors, Invitrogen Cd8b1 antibody (Caltag Laboratories, CT-CD8alpha) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to investigate which portions of CD28 are needed for T cells, Invitrogen Cd8b1 antibody (Invitrogen, clone 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to elucidate how TGF-beta signaling regulates the self-reactivity of peripheral T cells, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Nat Immunol (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 13-0081-82) was used in flow cytometry on mouse samples . Exp Hematol (2012) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse
In order to suggest that CD80 and CD86 contribute to polyclonal B cell activation mediated by Lat(Y136F) CD4 positive T cells, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples . Front Immunol (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study splenic natural killer T cells, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . EMBO J (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to elucidate age-specific tumor-associated immune dysfunction, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 5
In order to optimize a P. vivax vaccine, Invitrogen Cd8b1 antibody (Zymed/Invitrogen, clone 5H10) was used in flow cytometry on mouse samples (fig 5). Vaccine (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the contribution of IL-10 in mice infected with respiratory syncytial virus, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to investigate the effects of age on immune regulation and auto-aggressive T cells, Invitrogen Cd8b1 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . Aging Cell (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study the mechanisms by which the kinin receptor regulates multiple sclerosis development, Invitrogen Cd8b1 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to determine the role of granzyme B in immune regulation during viral infections, Invitrogen Cd8b1 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig 2). J Immunol (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; dogs
Invitrogen Cd8b1 antibody (eBiosciences, 11-0081-85) was used in flow cytometry on dogs samples . J Biol Chem (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 25-0081-81) was used in flow cytometry on mouse samples . J Immunol (2011) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to report coreceptor gene imprinting as a critical determinant of lineage fate determination in the thymus, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . EMBO J (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine the importance of ligand-activated N3 in promoting beta-selection and N1 intracellular domain-induced T cell leukemogenesis, Invitrogen Cd8b1 antibody (eBioScience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Mol Biol Cell (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2011) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to report how Tregs suppress early immune responses after vaccination, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2011) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig s1
In order to study the contribution of cathepsin K to human abdominal aortic aneurysm lesions, Invitrogen Cd8b1 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig s1). Arterioscler Thromb Vasc Biol (2012) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse; fig 5
In order to test if IL-17/IL-17 receptor-mediated responses contribute to T-cell-mediated concanavalin A-induced liver injury, Invitrogen Cd8b1 antibody (eBioscience, eBioH35-17.2) was used in flow cytometry on mouse samples (fig 5). Immunol Cell Biol (2012) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 2
In order to test if anti-CD8 Abs induce effector function, Invitrogen Cd8b1 antibody (Caltag, clone CT-CD8b) was used in flow cytometry on mouse samples (fig 2). J Immunol (2011) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to test if anti-CD8 Abs induce effector function, Invitrogen Cd8b1 antibody (Caltag, clone CT-CD8a) was used in flow cytometry on mouse samples (fig 2). J Immunol (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to examine how IL-27 influences Tregs in vivo, Invitrogen Cd8b1 antibody (Invitrogen, 53?C6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to identify signaling pathways that regulate thymic selection of un-manipulated polyclonal natural CD25(+)foxp3(+) regulatory T cells, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2011) ncbi
rat monoclonal (5H10)
  • immunohistochemistry - frozen section; mouse; 1:50; fig 4
In order to discuss the contribution of T cells to euglycemia, Invitrogen Cd8b1 antibody (Molecular Probes, MCD0801) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 4). J Surg Res (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6, 7
In order to use the Friend retrovirus mouse model to elucidate the mode of action of poly(I:C) in antiretroviral immunotherapy, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6, 7). J Immunol (2010) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse
In order to examine how maternal immune stimulation affects the adaptive immune system and pathobiology of the offspring, Invitrogen Cd8b1 antibody (Invitrogen, clone CT-CD8b) was used in flow cytometry on mouse samples . Brain Behav Immun (2011) ncbi
rat monoclonal (5H10)
  • immunocytochemistry; mouse; fig s3
In order to investigate factors that mediate memory B cells activation, Invitrogen Cd8b1 antibody (Caltag Laboratories, clone 5H10) was used in immunocytochemistry on mouse samples (fig s3). J Immunol (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6). J Immunol (2010) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 3
In order to test if upregulation of major histocompatibility complex class II and costimulatory molecules in the retina contributes to the regulation of CD4 T cells, Invitrogen Cd8b1 antibody (Invitrogen, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 3). Infect Immun (2010) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 3
In order to characterize a spread-deficient murine cytomegalovirus as a novel approach for betaherpesvirus vaccination, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 3). J Virol (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1, 2, 3
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1, 2, 3). Blood (2010) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; tbl 1
In order to report that a non-peptidyl mimetic of MnSOD reduces total body irradiation-induced tissue damage, Invitrogen Cd8b1 antibody (Caltag, RM2204) was used in flow cytometry on mouse samples (tbl 1). Free Radic Res (2010) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; tbl 1
In order to develop and characterize a novel model of heterologous pulmonary infection using Bordetella parapertussis and influenza virus, Invitrogen Cd8b1 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the role of bone marrow-derived cells in lymphangiogenesis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2009) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to test if deficiency of p19 in the allogeneic donor transplant reduces the inflammation caused by acute GVHD, Invitrogen Cd8b1 antibody (Caltag, RM2204) was used in flow cytometry on mouse samples (fig 4). Bone Marrow Transplant (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . Nat Med (2009) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the kinetics and functions of hematopoietic stem and progenitor cells in mice with Notch1-induced leukemia, Invitrogen Cd8b1 antibody (Caltag Laboratories, RM2215-3) was used in flow cytometry on mouse samples . Blood (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to investigate immune responses to antigen in skin, Invitrogen Cd8b1 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to evaluate immunotherapeutic regimens in mice chronically infected with lymphocytic choriomeningitis virus, Invitrogen Cd8b1 antibody (Caltag, 53.6.7) was used in flow cytometry on mouse samples (fig 1). J Virol (2009) ncbi
rat monoclonal (eBioH35-17.2 (H35-17.2))
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, H35-17.2) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 5
In order to report that estradiol prevents antigen loading of vaginal antigen presenting cells after intravaginal immunization, Invitrogen Cd8b1 antibody (CalTag, clone 5H10) was used in flow cytometry on mouse samples (fig 5). Vaccine (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study interactions between CD8 T cells, Toxoplasma gondii, and APCs in the brain, Invitrogen Cd8b1 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study interactions between CD8 T cells, Toxoplasma gondii, and APCs in the brain, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to track populations of T cells specific for a given peptide-major histocompatibility complex epitope, Invitrogen Cd8b1 antibody (Caltag-Invitrogen, MCD0830) was used in flow cytometry on mouse samples . Nat Protoc (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to assess the effects of early termination of infection on primary T cell expansion, subsequent memory cell development, and protective immunity, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine the contribution of CD4+ T cells in the generation of CD8+-T-cell responses following acute infection with HSV-1, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Virol (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to determine the contribution of CD4+ T cells in the generation of CD8+-T-cell responses following acute infection with HSV-1, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Virol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1c
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2009) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2, 4
In order to describe a role for Marco in the development of disease in BXSB mice, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 2, 4). J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to report that Ly49D engagement on T cells leads to T cell activation and TCR-independent effector functions of CD8 T cells, Invitrogen Cd8b1 antibody (eBioscience, 53.6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2009) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 5
In order to elucidate the role of VAMP8 in the thymus, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples (fig 5). Cell Tissue Res (2008) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to investigate the role of the PD-1 pathway in the maintenance of graft survival, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). J Immunol (2008) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to identify key signals required for the exponential expansion of specific CD8 positive mouse T cells in vivo, Invitrogen Cd8b1 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples . J Immunol (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to examine the role of IL-6 in the development of Th17 cells in experimental autoimmune encephalomyelitis, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s4
In order to assess the effects of Flt3 signaling on macrophage dendritic cell progenitors and on peripheral dendritic cells, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4). Nat Immunol (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2008) ncbi
rat monoclonal (53-6.7)
  • other; mouse; 5 mg/kg
Invitrogen Cd8b1 antibody (eBioscience, 53-6.72) was used in other on mouse samples at 5 mg/kg. Invest Ophthalmol Vis Sci (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to analyze protection against Plasmodium berghei by a single-dose simian adenovirus vector using a human cytomegalovirus promoter containing intron A, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Virol (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to study how multifactorial adjuvants show reduced toxicity and enhanced efficacy compared to unitary adjuvants as cancer vaccines, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Blood (2008) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to compare the requirements for positive selection and T(reg) development, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2007) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to provide evidence that lymphotoxin pathway signals regulate development of the composition and organization of the thymus, specifically the medullary epithelial compartment, Invitrogen Cd8b1 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . J Immunol (2007) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to report murine CD4(+) and CD8(+) T cell responses to male-specific minor histocompatibility antigens, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2007) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate whether hematopoietic cells transduce canonical Wnt signals in the absence of beta- and gamma-catenin, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Blood (2008) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to indicate that defective DRF1 expression or mammalian diaphanous 1 function contributes to myeloid malignancies and suggest mammalian diaphanous 1 as an attractive therapeutic target in human myeloproliferative syndrome and myelodysplastic syndrome, Invitrogen Cd8b1 antibody (Invitrogen/Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . Cancer Res (2007) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study autoimmune-mediated pathology in chronic graft-versus-host disease due to the absence of regulatory T-cell control of TH1 and TH17 cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2007) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to assess the effects of C5a on IL-12p70 secretion by murine dendritic cells and Th1 immunity, Invitrogen Cd8b1 antibody (Caltag Laboratories, RM2201-3) was used in flow cytometry on mouse samples . J Leukoc Biol (2007) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
In order to demonstrate that cerebral malaria development is independent of TLR2, 4 and 9, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . Med Microbiol Immunol (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to assess the role and mechanism of Bifidobacterium longum BB536 probiotic in suppressing antigen-induced Th2 immune response in vitro, Invitrogen Cd8b1 antibody (e-bioscience, 53-6.7) was used in flow cytometry on mouse samples . Microbiol Immunol (2007) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to develop a system for the decoration of enveloped viruses with functionally active cytokines, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Virol (2007) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry - paraffin section; fruit fly ; 1:100
In order to describe a basic method for dissection and immunofluorescence staining of the Drosophila brain at various developmental stages, Invitrogen Cd8b1 antibody (Invitrogen, RM2200) was used in immunohistochemistry - paraffin section on fruit fly samples at 1:100. Nat Protoc (2006) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to identify targets of HDAC7 in T cells, Invitrogen Cd8b1 antibody (Caltag Laboratories, MCD0805) was used in flow cytometry on mouse samples . Mol Cell Biol (2007) ncbi
rat monoclonal (CT-CD8a)
  • immunocytochemistry; fruit fly ; 1:100
In order to discuss the uses of mosaic analysis with a repressible cell marker (MARCM), Invitrogen Cd8b1 antibody (CALTAG, RM2200) was used in immunocytochemistry on fruit fly samples at 1:100. Nat Protoc (2006) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to study a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo known as immunostimulatory RNA, Invitrogen Cd8b1 antibody (Caltag, CD8alpha) was used in flow cytometry on mouse samples (fig 1). Int Immunol (2007) ncbi
rat monoclonal (5H10)
  • immunohistochemistry - frozen section; mouse
In order to characterize "class I APC-bald" mice and see if they develop diabetes, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in immunohistochemistry - frozen section on mouse samples . Proc Natl Acad Sci U S A (2007) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
In order to characterize "class I APC-bald" mice and see if they develop diabetes, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2007) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to assess how FTY720-treatment affects T cell populations, Invitrogen Cd8b1 antibody (ebiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Int Immunopharmacol (2006) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to report that dectin-1 deficiency renders mice susceptible to infection with Candida albicans, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . Nat Immunol (2007) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to identify the cells that are producing gamma interferon during infection with Listeria monocytogenes, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). Infect Immun (2007) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Circulation (2006) ncbi
rat monoclonal (5H10)
  • immunohistochemistry - paraffin section; mouse
In order to report a role for CD4 positive alphabeta T cells in S. aureus infections, Invitrogen Cd8b1 antibody (Caltag, MCD0820) was used in immunohistochemistry - paraffin section on mouse samples . Proc Natl Acad Sci U S A (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to explore how Melan-A expression in dendritic cells fails to elicit T-cell responses, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to demonstrate that software designed for transcriptomics applications can be used in multiparameter flow cytometry, Invitrogen Cd8b1 antibody (ebiosciences, 53-6.7) was used in flow cytometry on mouse samples . Cytometry A (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to study the use of a recombinant lentivector to immunize against the melanoma-associated antigen, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2006) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to study the use of a recombinant lentivector to immunize against the melanoma-associated antigen, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2006) ncbi
rat monoclonal (KT15)
  • immunohistochemistry; mouse; fig 5
In order to show that EtxB can block diabetes, Invitrogen Cd8b1 antibody (Biosource, KT15) was used in immunohistochemistry on mouse samples (fig 5). Immunology (2006) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to clone and characterize Siglec-H, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Blood (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 7
In order to study the in vivo role of cytokine- and antigen-mediated T cell activation in the resistance to Burkholderia pseudomallei, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 7). J Infect Dis (2006) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the influence of gut ischemia/reperfusion on gut-associated lymphoid tissue mass and function, Invitrogen Cd8b1 antibody (Caltag, CTCD8a) was used in flow cytometry on mouse samples . Crit Care Med (2006) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to characterize T cells from mice infected with Theiler's murine encephalomyelitis virus, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 1). J Virol (2005) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2005) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to study T cell progenitors in the adult thymus, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 1). J Immunol (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to conclude that bone marrow committed T cell progenitors can generate functional T cells via an extrathymic pathway, Invitrogen Cd8b1 antibody (Caltag, CT-CD8) was used in flow cytometry on mouse samples . J Immunol (2005) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to evaluate the tuberculosis vaccine candidate Mtb72F, Invitrogen Cd8b1 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . Infect Immun (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to characterize dendritic cells in mice infected with Trichuris muris, Invitrogen Cd8b1 antibody (Caltag, CTCD8a) was used in flow cytometry on mouse samples . Parasitol Res (2005) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 5
In order to optimize the targeted delivery of the ErbB2 tumor antigen to antigen presenting cells in vivo, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 5). J Immunol (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine graft-versus-host disease and emergent autoimmunity, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to use infection of the respiratory tract with paramyxovirus simian virus 5 to study lung CD8+ T cell responses, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Virol (2005) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to report that Runx3 drives thymocytes to select the CD4-8+ lineage, Invitrogen Cd8b1 antibody (Invitrogen Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2005) ncbi
rat monoclonal (5H10)
  • other; mouse
  • flow cytometry; mouse
In order to elucidate the lack of cytolysis of CD8+ tumor-infiltrating lymphocytes, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in other on mouse samples and in flow cytometry on mouse samples . J Immunol (2005) ncbi
rat monoclonal (CT-CD8b)
  • other; mouse
In order to elucidate the lack of cytolysis of CD8+ tumor-infiltrating lymphocytes, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in other on mouse samples . J Immunol (2005) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study mycobacterial dissemination and immune-cell trafficking in tuberculosis, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Infect Dis (2004) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to study the effects of stimulating CD137 in vivo after tumor lysate-pulsed dendritic cell vaccination, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2004) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to investigate the differentiation of CD4+CD25+ regulatory T cells, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Exp Med (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the differentiation of CD4+CD25+ regulatory T cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Exp Med (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to identify a role for TRAIL in apoptosis during listeriosis, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • immunocytochemistry; mouse; fig 5
In order to study the essential role for the binding to and killing of activated macrophages by gamma delta T cells by Fas-Fas ligand interactions, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in immunocytochemistry on mouse samples (fig 5). J Immunol (2004) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to investigate mechanisms that regulate thymus size, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 5). J Immunol (2004) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to investigate the contribution of GRAIL and GRAIL-interacting proteins to CD4 T cell anergy, Invitrogen Cd8b1 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to determine the contribution of IFN during infection with Leishmania major, Invitrogen Cd8b1 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 4). J Immunol (2004) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the use of three-domain single-chain T-cell receptors, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples . Cancer Gene Ther (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to test if CD4 regulatory cells prevent autologous graft-vs.-host disease, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Am J Transplant (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to demonstrate that deletion p18(INK4C) results in improved long-term engraftment, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 4). Nat Cell Biol (2004) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to determine the fate of autoreactive CD4+T cells in HNT-TCR x GFAP-HA double transgenic mice, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Autoimmun (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the fate of autoreactive CD4+T cells in HNT-TCR x GFAP-HA double transgenic mice, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Autoimmun (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; tbl 1
In order to analyze NOD mice after irradiation and bone marrow transplantation and the persistence of recipient lymphocytes, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (tbl 1). J Autoimmun (2004) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 6
In order to characterize a new mouse model of rheumatoid arthritis, Invitrogen Cd8b1 antibody (Caltag, CTCD8) was used in flow cytometry on mouse samples (fig 6). Int Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 6
In order to characterize a new mouse model of rheumatoid arthritis, Invitrogen Cd8b1 antibody (Caltag, CTCD8) was used in flow cytometry on mouse samples (fig 6). Int Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to test if higher numbers of hematopoietic stem cells correlate with the speed of immune reconstitution in a congenic transplantation mouse model, Invitrogen Cd8b1 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 1). Blood (2004) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to test if higher numbers of hematopoietic stem cells correlate with the speed of immune reconstitution in a congenic transplantation mouse model, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). Blood (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 6
In order to test if Tyk2 kinase is required for protection against Leishmania major, Invitrogen Cd8b1 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 6). Eur J Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to identify cellular mechanisms that contribute to susceptibility/resistance to tuberculosis, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Clin Exp Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to assess the contribution of DC function in non-obese diabetic mice, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Clin Exp Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study the initiation of insulitis, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Exp Med (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to test if tetramers distinguish between high and low avidity T cell clones, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 1
In order to test if tetramers distinguish between high and low avidity T cell clones, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to test if tetramers distinguish between high and low avidity T cell clones, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; tbl 1
In order to test if recombinant human growth hormone promotes immune recovery after allogeneic T-cell-depleted bone marrow transplantation, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (tbl 1). Exp Hematol (2003) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to study CCR6 expression by T lymphocyte precursors undergoing extrathymic differentiation in intestinal cryptopatches, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 1
In order to study CCR6 expression by T lymphocyte precursors undergoing extrathymic differentiation in intestinal cryptopatches, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to determine the influence of in vivo-mobilized immature donor DC plus anti-CD40L mAb on vascular sclerosis in functional murine aortic allografts, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). Transplantation (2003) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to investigate factors that mediate induction and maintenance of the 3D configuration of the epithelial network in fetal thymic lobes in vitro, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 1). J Histochem Cytochem (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the role of granulocyte colony-stimulating factor on hematopoietic progenitors in vivo, Invitrogen Cd8b1 antibody (Zymed, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to examine early T cell progenitor development in the nu/nu bone marrow, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to investigate the relationship between progenitors and TCRbeta transcription, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 4). Cell Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 6, 7
In order to report that iNOS and phox are both required for the control of L. major in different tissues and at different stages, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 6, 7). Eur J Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to test if NKT cells produce IL-4 in response to T. muris infection and induce an Th2 response, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Parasite Immunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to examine the role of SOCS-1 in regulating inflammatory and immune responses in acute inflammatory arthritis, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Clin Invest (2003) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; tbl 1
In order to assess the proliferative potential of thymic progenitors that are T cell lineage restricted, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (tbl 1). Eur J Immunol (2003) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse
In order to study the effect of dietary cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on immunoglobulin and cytokine production from spleen lymphocytes in C57BL/6J mice, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples . J Nutr (2003) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 4
In order to report that polarized type-2 immune responses are initiated independently of adaptive immunity, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 4). Nature (2002) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to examine the T cell responses in cyclophosphamide-treated mice after systemic infection with Candida albicans, Invitrogen Cd8b1 antibody (Caltag, YTS 169.4) was used in flow cytometry on mouse samples . Cell Immunol (2002) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study the effect of infection age using severe respiratory syncytial virus, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Exp Med (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to suggest that p38 is involved in positive selection of T cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to investigate the control of functional avidity in response to viral infection, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 2). J Immunol (2002) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 2
In order to investigate the control of functional avidity in response to viral infection, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples (fig 2). J Immunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to investigate graft-versus-leukemia, Invitrogen Cd8b1 antibody (Caltag Laboratories, clone CT-CD8a) was used in flow cytometry on mouse samples (fig 1). Blood (2002) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry; mouse; fig 1
In order to study the cellular infiltrate during central nervous system inflammation, Invitrogen Cd8b1 antibody (Caltag, clone CT-CD8a) was used in immunohistochemistry on mouse samples (fig 1). J Neuroimmunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to test if T-cell-specific expression of p300 alters GR-TCR cross talk between thymocytes, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Mol Cell Biol (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to characterize the differences in dendritic cell generation in vivo caused by non-MHC NOD genes, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Int Immunol (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the role of VCAM-1 in collagen-induced arthritis, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples . Clin Exp Immunol (2002) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 3
In order to explore the role of E2A in T cell lineage, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples (fig 3). J Immunol (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to characterize two subsets of mouse CD8 T cells, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the origin and involvement of CD8alpha(-) and CD8alpha(+) DCs in antiviral immune responses in vivo, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the origins of CD8alpha+ and CD8alpha- dendritic cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
In order to elucidate the role of beta2 integrins in T cell-mediated immune responses, Invitrogen Cd8b1 antibody (noco, 53-6.7) was used in flow cytometry on mouse samples (fig 6). J Clin Invest (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4, 5
In order to study loss of CD8+ cells in IL-15Ralpha(-/-) mice, Invitrogen Cd8b1 antibody (CALTAG, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 4, 5). J Immunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to compare myeloid and lymphoid recovery using bone marrow and cord blood as sources of stem cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2002) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to determine the role of CD8alpha-(myeloid) DCs in organ transplantation, Invitrogen Cd8b1 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to identify the source of the early IFN-gamma after injection with anti-CD3, Invitrogen Cd8b1 antibody (Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of IL-10 in mycobacterial infections, Invitrogen Cd8b1 antibody (Caltag, clone CT-CD8) was used in flow cytometry on mouse samples (fig 2). Scand J Immunol (2001) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of IL-10 in mycobacterial infections, Invitrogen Cd8b1 antibody (Caltag, clone CT-CD8) was used in flow cytometry on mouse samples (fig 2). Scand J Immunol (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study the cell cycle using FADD(-/-) peripheral T cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Biol Chem (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to test if specific subsets of cells in allogeneic bone marrow transplants can treat the BCL(1) B-cell lymphoma without inducing graft verses host disease, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2001) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 1
In order to characterize murine tumor-infiltrating lymphocytes, Invitrogen Cd8b1 antibody (CalTag, CT-CD8b) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to examine multipotent progenitors from early fetuses, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 3, 4
In order to investigate the effect of IL-18 on NKT cells, Invitrogen Cd8b1 antibody (Caltag, YTS 169.4) was used in flow cytometry on mouse samples (fig 3, 4). J Immunol (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to study regulation of the lck in T cell lineage commitment, Invitrogen Cd8b1 antibody (Caltag, CT-CD8alpha-APC) was used in flow cytometry on mouse samples (fig 1). Int Immunol (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 3
In order to assess the effects of folate analogues on superantigen-reactive peripheral T cells in vivo, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 3). Int Immunol (2001) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to investigate the role of AML1 in T cell development, Invitrogen Cd8b1 antibody (Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the origin of CD8alpha(+) and CD8alpha(-) DCs, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to examine the contribution of different DC subsets during infection with Cryptococcus neoformans, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 2). J Immunol (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the expression of endothelial addressins and integrins on T cells during infection with Mycobacterium tuberculosis, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Immunol (2000) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry - frozen section; mouse
In order to determine the role of polymorphonuclear neutrophils in Chlamydophila abortus-infected mice, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in immunohistochemistry - frozen section on mouse samples . Infect Immun (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to determine the phenotype and function of T cells that prevent diabetes, Invitrogen Cd8b1 antibody (Caltag, CT-CD8) was used in flow cytometry on mouse samples (fig 1). J Immunol (2000) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 1
In order to determine the phenotype and function of T cells that prevent diabetes, Invitrogen Cd8b1 antibody (Caltag, CT-CD8) was used in flow cytometry on mouse samples (fig 1). J Immunol (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to identify a rare population of cells in the adult mouse bone marrow that generates CD4(+) and CD8(+) TCRalphabeta(+) T cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to describe a clonal system that supports the development of T and natural killer cells evenly, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Exp Med (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to investigate the aorta-gonad-mesonephros region as a source of hemopoietic progenitors, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine the role of IL-7R signaling in gamma/delta T cell development, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (1999) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse
In order to investigate the role of Id3 in tissue and embryo development, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples . Mol Cell Biol (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the importance of T cells in Chlamydia pneumoniae infection, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Immunology (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to study Fas-mediated activation-induced cell death in naive and primed T cells, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study activation-induced nonresponsiveness of T cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to investigate hyper responsive CD8 T cells, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . Int Immunol (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to characterize in vitro-generated dendritic cells, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Immunology (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the contribution of NK1.1(-) and NK1.1(+) T cell subsets to GVHD, Invitrogen Cd8b1 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples . J Exp Med (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to assess if progenitors colonizing the thymus are T cell lineage restricted, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 2, 3
In order to further characterize mice hemizygous for scurfy, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples (fig 2, 3). J Immunol (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1, 2
In order to examine the effect of dietary docosahexaenoic acid on the surface molecules involved in T cell proliferation, Invitrogen Cd8b1 antibody (Caltag, YTS-169.4) was used in flow cytometry on mouse samples (fig 1, 2). Biochim Biophys Acta (1999) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study FasL expression on thyrocytes, Invitrogen Cd8b1 antibody (Caltag, 53?C6.72) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to assess experimental autoimmune encephalomyelitis in mice deficient in IL-6, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 4). J Immunol (1998) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to use T cells from BALB mice and study IL-4 production, Invitrogen Cd8b1 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples . J Exp Med (1998) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to compare gut and peripheral T cell responses after staphylococcal enterotoxin treatment, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (1998) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to analyze the cell activation and proliferation requirements for the deletion of viral superantigen-reactive Vbeta8.1 T-cell receptor transgenic thymocytes, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (1998) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to develop a mouse model to study the ability of a glycoprotein conjugate vaccine to induce immunologic memory for the polysaccharide moiety, Invitrogen Cd8b1 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Infect Immun (1998) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; fig 4
In order to determine if the microbiota contributes to autoimmunity in IL-2 deficient mice, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples (fig 4). J Immunol (1998) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to determine if the microbiota contributes to autoimmunity in IL-2 deficient mice, Invitrogen Cd8b1 antibody (Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 4). J Immunol (1998) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to characterize different populations of mouse lymph node dendritic cells, Invitrogen Cd8b1 antibody (Caltag, T-CD8a) was used in flow cytometry on mouse samples . J Immunol (1998) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to elucidate the role of B7 in thymic selection, Invitrogen Cd8b1 antibody (Caltag, clone 53.6.7) was used in flow cytometry on mouse samples (fig 1). Int Immunol (1997) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 2
In order to elucidate the pathway and cytokine regulation of NK cell development in vitro, Invitrogen Cd8b1 antibody (Caltag Laboratories, YTS 169.4) was used in flow cytometry on mouse samples (fig 2). Blood (1997) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to report that bGH stimulates the proliferation of activated murine T cells, Invitrogen Cd8b1 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 3). Endocrinology (1997) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to test if pregnancies and gender influence the cellar changes observed during ageing in mice, Invitrogen Cd8b1 antibody (Caltag, YTS169-4) was used in flow cytometry on mouse samples . Clin Exp Immunol (1997) ncbi
rat monoclonal (CT-CD8b)
  • flow cytometry; mouse; tbl 1
In order to demonstrate that the Ras/Raf/MAPK pathway is constitutively activated in lck-transformed immature thymoblasts, Invitrogen Cd8b1 antibody (Caltag, CT-CD8b) was used in flow cytometry on mouse samples (tbl 1). Int Immunol (1997) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to test if different activation thresholds distinguish naive from memory CD8+ T cell populations, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Exp Med (1996) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to report that FcR is a useful marker to isolate the most immature population of murine fetal thymic cells, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Exp Med (1996) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to study the long-term role of L-selectin-mediated migration in the maintenance of leukocyte subpopulations, Invitrogen Cd8b1 antibody (Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 5). J Immunol (1996) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to develop and characterize a MV1-induced vasculitis model, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 1). Clin Exp Immunol (1996) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to report that TAN1 is an oncoprotein, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Exp Med (1996) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; tbl 1
In order to suggest that T lymphocyte lineage commitment and peripheral function does not depend on functional CD4, Invitrogen Cd8b1 antibody (CalTag, YTS 169.4) was used in flow cytometry on mouse samples (tbl 1). Science (1993) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 3
In order to test the requirement for CD8 to interact with class I MHC molecules to promote CD4-CD8- T cells in lpr/lpr mice, Invitrogen Cd8b1 antibody (Caltag, YTS 169.4) was used in flow cytometry on mouse samples (fig 3). J Immunol (1995) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to use an in vivo transfer system to analyze the progeny of CD4+ T cells from B6-lpr/lpr mice, Invitrogen Cd8b1 antibody (Caltag, YTS-169.4) was used in flow cytometry on mouse samples (fig 1). J Immunol (1994) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl 1
In order to report expression of Lyt-1, Lyt-2, and Lyt-3 on T cell subpopulations, Invitrogen Cd8b1 antibody (noco, 53-6.7) was used in flow cytometry on mouse samples (tbl 1). J Exp Med (1980) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; tbl 1
  • ELISA; mouse; tbl 1
In order to compare the domains needed for LFA-1 and Mac-1 to bind ICAM-1, Invitrogen Cd8b1 antibody (CalTag, YTS 169.4) was used in flow cytometry on mouse samples (tbl 1) and in ELISA on mouse samples (tbl 1). Cell (1991) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 5
In order to develop a new method to isolate dendritic cells and characterize splenic and thymic dendritic cells, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 5). J Exp Med (1992) ncbi
rat monoclonal (53-6.7)
  • other; mouse; fig 2
In order to assess T-cell surface molecules regulating T-cell interleukin 2 responses, Invitrogen Cd8b1 antibody (noco, 53-6.72) was used in other on mouse samples (fig 2). Proc Natl Acad Sci U S A (1992) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; tbl 2
In order to describe the cells that transfer adoptive murine experimental hypersensitivity pneumonitis, Invitrogen Cd8b1 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (tbl 2). Am Rev Respir Dis (1992) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1C
  • immunoprecipitation; mouse; fig 3F
In order to test the effects of xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens, Invitrogen Cd8b1 antibody (noco, 53-6.7) was used in flow cytometry on mouse samples (fig 1C) and in immunoprecipitation on mouse samples (fig 3F). Immunol Rev (1979) ncbi
BioLegend
rat monoclonal (53-5.8)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend Cd8b1 antibody (Biolegend, 140404) was used in flow cytometry on mouse samples (fig 3d). J Immunother Cancer (2021) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s22a
BioLegend Cd8b1 antibody (Biolegend, YTS156.7.7) was used in flow cytometry on mouse samples at 1:100 (fig s22a). Nat Commun (2021) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig s2a, 5d, 5h
BioLegend Cd8b1 antibody (Biolegend, YTS156.7.7) was used in flow cytometry on mouse samples (fig s2a, 5d, 5h). Front Immunol (2021) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; 1:200; fig 2b
BioLegend Cd8b1 antibody (Biolegend, 53-5.8) was used in flow cytometry on mouse samples at 1:200 (fig 2b). Front Immunol (2021) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; 2 ug/ml; loading ...; fig s29b
BioLegend Cd8b1 antibody (Biolegend, 53-5.8) was used in flow cytometry on mouse samples at 2 ug/ml (fig s29b). Science (2020) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s19d
BioLegend Cd8b1 antibody (Biolegend, 126613) was used in flow cytometry on mouse samples at 1:100 (fig s19d). Nat Commun (2020) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; fig s2a
BioLegend Cd8b1 antibody (Biolegend, 126620) was used in flow cytometry on mouse samples (fig s2a). JCI Insight (2019) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig 1a, 1c, 1d, 5d, s5a
BioLegend Cd8b1 antibody (BioLegend, 126606) was used in flow cytometry on mouse samples (fig 1a, 1c, 1d, 5d, s5a). Cell Rep (2019) ncbi
rat monoclonal (YTS156.7.7)
  • mass cytometry; mouse; loading ...; fig 3, s2
BioLegend Cd8b1 antibody (Biolegend, 126602) was used in mass cytometry on mouse samples (fig 3, s2). Science (2019) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Cd8b1 antibody (Biolegend, 126619) was used in flow cytometry on mouse samples (fig 1c). Cell (2019) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s2f, s2g
BioLegend Cd8b1 antibody (Biolegend, 126608) was used in flow cytometry on mouse samples at 1:100 (fig s2f, s2g). Nat Commun (2019) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend Cd8b1 antibody (BioLegend, YTS156.7.7) was used in flow cytometry on mouse samples at 1:100. Nature (2019) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend Cd8b1 antibody (Biolegend, YTS156.7.7) was used in flow cytometry on mouse samples (fig 3e). Int J Cancer (2019) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig 3a, 3f
BioLegend Cd8b1 antibody (BioLegend, YTS156.7.7) was used in flow cytometry on mouse samples (fig 3a, 3f). JCI Insight (2018) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Cd8b1 antibody (BioLegend, YTS156.7.7) was used in flow cytometry on mouse samples (fig 1e). Oncoimmunology (2018) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Cd8b1 antibody (eBioscience, 53-5.8) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2018) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; loading ...; fig s3a
BioLegend Cd8b1 antibody (BioLegend, 53-5.8) was used in flow cytometry on mouse samples (fig s3a). J Immunol (2018) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; fig 2a
BioLegend Cd8b1 antibody (BioLegend, 140404) was used in flow cytometry on mouse samples (fig 2a). Cell (2018) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend Cd8b1 antibody (Biolegend, 53-5.8) was used in flow cytometry on mouse samples (fig 5b). J Virol (2018) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend Cd8b1 antibody (BioLegend, 53-5.8) was used in flow cytometry on mouse samples (fig s5b). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Cd8b1 antibody (BioLegend, YTS156.7.7) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2017) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend Cd8b1 antibody (Biolegend, YTS156.7.7) was used in flow cytometry on mouse samples (fig 2b). Nature (2017) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; fig s1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend Cd8b1 antibody (BioLegend, 126609) was used in flow cytometry on mouse samples (fig s1). Cell (2016) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; loading ...; fig 4g
In order to assess the contribution of interferon-induced transmembrane protein 3 to West Nile virus infection, BioLegend Cd8b1 antibody (Biolegend, 126609) was used in flow cytometry on mouse samples (fig 4g). J Virol (2016) ncbi
rat monoclonal (YTS156.7.7)
BioLegend Cd8b1 antibody (BioLegend, YTS156.7.7) was used . J Immunol (2014) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, BioLegend Cd8b1 antibody (Biolegend, YTS156.7.7) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (YTS156.7.7)
  • flow cytometry; mouse; fig 2a
BioLegend Cd8b1 antibody (BioLegend, YTS156.7.7) was used in flow cytometry on mouse samples (fig 2a). Immunol Lett (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (32-M4)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 9d
Santa Cruz Biotechnology Cd8b1 antibody (Santa Cruz, sc-1177) was used in immunohistochemistry on mouse samples at 1:50 (fig 9d). J Neuroinflammation (2020) ncbi
Bio X Cell
rat monoclonal (53-5.8)
  • blocking or activating experiments; mouse; fig 2a
Bio X Cell Cd8b1 antibody (BioXcell, 53-5.8) was used in blocking or activating experiments on mouse samples (fig 2a). JCI Insight (2018) ncbi
rat monoclonal (53-5.8)
  • other; mouse; loading ...; fig 2f
Bio X Cell Cd8b1 antibody (BioXcell, 5358) was used in other on mouse samples (fig 2f). Science (2018) ncbi
BD Biosciences
rat monoclonal (53-5.8)
  • flow cytometry; mouse; 1:300; loading ...; fig 1d
BD Biosciences Cd8b1 antibody (BD Biosciences, 553041) was used in flow cytometry on mouse samples at 1:300 (fig 1d). J Clin Invest (2018) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; loading ...; fig s1a
In order to discuss methods to improve needle-free intradermal injections, BD Biosciences Cd8b1 antibody (BD Biosciences, 553038) was used in flow cytometry on mouse samples (fig s1a). Sci Rep (2016) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; 1:300; loading ...; fig s2a
In order to investigate the role of IL-1beta produced by a T helper 17 cell-intrinsic ASC-NLRP3-caspase-8 inflammasome in experimental autoimmune encephalomyelitis, BD Biosciences Cd8b1 antibody (BD Biosciences, 553041) was used in flow cytometry on mouse samples at 1:300 (fig s2a). Nat Immunol (2016) ncbi
rat monoclonal (H35-17.2)
  • flow cytometry; mouse; fig 4
BD Biosciences Cd8b1 antibody (BD, 550798) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2015) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; 10-20 ug/ml
BD Biosciences Cd8b1 antibody (BD Biosciences, 53-5.8) was used in flow cytometry on mouse samples at 10-20 ug/ml. Immunology (2015) ncbi
rat monoclonal (H35-17.2)
  • flow cytometry; mouse; fig 8
BD Biosciences Cd8b1 antibody (BD Pharmigen, eBioH35-17.2) was used in flow cytometry on mouse samples (fig 8). PLoS ONE (2015) ncbi
rat monoclonal (53-5.8)
  • flow cytometry; mouse; fig 5
In order to test if a viral cyclin-CDK6 complex is a regulator of the Notch receptor, BD Biosciences Cd8b1 antibody (BD PharMingen, 53-5.8) was used in flow cytometry on mouse samples (fig 5). Cell Cycle (2014) ncbi
rat monoclonal (H35-17.2)
  • flow cytometry; mouse
BD Biosciences Cd8b1 antibody (BD Biosciences, H35-17.2) was used in flow cytometry on mouse samples . Exp Parasitol (2014) ncbi
rat monoclonal (H35-17.2)
  • flow cytometry; mouse
In order to study the role of CD4 T cells during mixed antibody-mediated rejection of renal allografts, BD Biosciences Cd8b1 antibody (BD Biosciences, H35-17.2) was used in flow cytometry on mouse samples . Am J Transplant (2014) ncbi
Articles Reviewed
  1. Kettwig M, Ternka K, Wendland K, Krüger D, Zampar S, Schob C, et al. Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy. Nat Commun. 2021;12:6530 pubmed publisher
  2. Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clement S, Maeder C, et al. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel). 2021;13: pubmed publisher
  3. Hoefflin R, Harlander S, Abhari B, Peighambari A, Adlesic M, Seidel P, et al. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2021;13: pubmed publisher
  4. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  5. Tian N, Hu L, Lu Y, Tong L, Feng M, Liu Q, et al. TKT maintains intestinal ATP production and inhibits apoptosis-induced colitis. Cell Death Dis. 2021;12:853 pubmed publisher
  6. Tillie R, Theelen T, van Kuijk K, Temmerman L, de Bruijn J, Gijbels M, et al. A Switch from Cell-Associated to Soluble PDGF-B Protects against Atherosclerosis, despite Driving Extramedullary Hematopoiesis. Cells. 2021;10: pubmed publisher
  7. Tulotta C, Lefley D, Moore C, Amariutei A, Spicer Hadlington A, Quayle L, et al. IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. NPJ Breast Cancer. 2021;7:95 pubmed publisher
  8. Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36:109412 pubmed publisher
  9. James O, Vandereyken M, Marchingo J, Singh F, Bray S, Wilson J, et al. IL-15 and PIM kinases direct the metabolic programming of intestinal intraepithelial lymphocytes. Nat Commun. 2021;12:4290 pubmed publisher
  10. Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, et al. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy. J Immunother Cancer. 2021;9: pubmed publisher
  11. Lu J, Wang W, Li P, Wang X, Gao C, Zhang B, et al. MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice. Cell Death Discov. 2021;7:165 pubmed publisher
  12. Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs J, Wawrzyniak M, et al. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci. 2021;22: pubmed publisher
  13. Gehlsen U, Stary D, Maass M, Riesner K, Musial G, Stern M, et al. Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis. Int J Mol Sci. 2021;22: pubmed publisher
  14. Ryu S, Shchukina I, Youm Y, Qing H, Hilliard B, Dlugos T, et al. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. elife. 2021;10: pubmed publisher
  15. Ho D, Tsui Y, Chan L, Sze K, Zhang X, Cheu J, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12:3684 pubmed publisher
  16. Ramos M, Tian L, de Ruiter E, Song C, Paucarmayta A, Singh A, et al. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. elife. 2021;10: pubmed publisher
  17. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  18. Zhang X, Liu X, Zhou W, Du Q, Yang M, Ding Y, et al. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance. Cell Mol Gastroenterol Hepatol. 2021;12:1179-1199 pubmed publisher
  19. West J, Austin E, Rizzi E, Yan L, Tanjore H, Crabtree A, et al. KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models. Int J Mol Sci. 2021;22: pubmed publisher
  20. Liu K, Jing N, Wang D, Xu P, Wang J, Chen X, et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 2021;54:e13056 pubmed publisher
  21. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  22. Reis M, Willis G, Fernandez Gonzalez A, Yeung V, Taglauer E, Magaletta M, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia. Front Immunol. 2021;12:640595 pubmed publisher
  23. Zhang S, Li L, Xie D, Reddy S, Sleasman J, Ma L, et al. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1. Front Immunol. 2021;12:620437 pubmed publisher
  24. Flamini S, Sergeev P, Viana de Barros Z, Mello T, Biagioli M, Paglialunga M, et al. Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment. Cell Death Dis. 2021;12:421 pubmed publisher
  25. Datta M, Staszewski O. Hdac1 and Hdac2 are essential for physiological maturation of a Cx3cr1 expressing subset of T-lymphocytes. BMC Res Notes. 2021;14:135 pubmed publisher
  26. Roux C, Mucciolo G, Kopecka J, Novelli F, Riganti C, Cappello P. IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine. Antioxidants (Basel). 2021;10: pubmed publisher
  27. Sánchez del Campo L, Martí Díaz R, Montenegro M, González Guerrero R, Hernández Caselles T, Martínez Barba E, et al. MITF induces escape from innate immunity in melanoma. J Exp Clin Cancer Res. 2021;40:117 pubmed publisher
  28. Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12:1940 pubmed publisher
  29. Liu Y, Li X, Zhang H, Zhang M, Wei Y. HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer. Oncogene. 2021;40:2230-2242 pubmed publisher
  30. Mpekris F, Panagi M, Voutouri C, Martin J, Samuel R, Takahashi S, et al. Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis. Adv Sci (Weinh). 2021;8:2001917 pubmed publisher
  31. Zahedi K, Brooks M, Barone S, Rahmati N, Murray Stewart T, Dunworth M, et al. Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia. J Neuroinflammation. 2020;17:301 pubmed publisher
  32. Ishii K, Pouzolles M, Chien C, Erwin Cohen R, Kohler M, Qin H, et al. Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients. J Clin Invest. 2020;130:5425-5443 pubmed publisher
  33. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  34. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  35. Neuper T, Neureiter D, Sarajlic M, Strandt H, Bauer R, Schwarz H, et al. IL-31 transgenic mice show reduced allergen-induced lung inflammation. Eur J Immunol. 2021;51:191-196 pubmed publisher
  36. Ho J, Angel M, Ma Y, Sloan E, Wang G, Martínez Romero C, et al. Hybrid Gene Origination Creates Human-Virus Chimeric Proteins during Infection. Cell. 2020;181:1502-1517.e23 pubmed publisher
  37. Zhou S, Wu W, Wang Z, Wang Z, Su Q, Li X, et al. RelB regulates the homeostatic proliferation but not the function of Tregs. BMC Immunol. 2020;21:37 pubmed publisher
  38. Lubos N, van der Gaag S, Gerçek M, Kant S, Leube R, Krusche C. Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020;115:42 pubmed publisher
  39. Ruscetti M, Morris J, Mezzadra R, Russell J, Leibold J, Romesser P, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 2020;181:424-441.e21 pubmed publisher
  40. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  41. Gao M, Wang T, Ji L, Bai S, Tian L, Song H. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer. Front Immunol. 2020;11:366 pubmed publisher
  42. Doll J, Hoebe K, Thompson R, Sawtell N. Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction. PLoS Pathog. 2020;16:e1008296 pubmed publisher
  43. Hu X, Deng Q, Ma L, Li Q, Chen Y, Liao Y, et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 2020;30:229-243 pubmed publisher
  44. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  45. Aslan K, Turco V, Blobner J, Sonner J, Liuzzi A, Núñez N, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931 pubmed publisher
  46. Abadie V, Kim S, Lejeune T, Palanski B, Ernest J, Tastet O, et al. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease. Nature. 2020;578:600-604 pubmed publisher
  47. Jaynes J, Sable R, Ronzetti M, Bautista W, Knotts Z, Abisoye Ogunniyan A, et al. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci Transl Med. 2020;12: pubmed publisher
  48. Tizian C, Lahmann A, Hölsken O, Cosovanu C, Kofoed Branzk M, Heinrich F, et al. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells. elife. 2020;9: pubmed publisher
  49. Cohen G, Chandran P, Lorsung R, Tomlinson L, Sundby M, Burks S, et al. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel). 2020;12: pubmed publisher
  50. Williams G, Marmion D, Schonhoff A, Jurkuvenaite A, Won W, Standaert D, et al. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathol. 2020;139:855-874 pubmed publisher
  51. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  52. Liu Z, Wen J, Wu C, Hu C, Wang J, Bao Q, et al. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma. Aging (Albany NY). 2020;12:1213-1236 pubmed publisher
  53. Bliss C, Parsons A, Nachbagauer R, Hamilton J, Cappuccini F, Ulaszewska M, et al. Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice. Mol Ther Methods Clin Dev. 2020;16:108-125 pubmed publisher
  54. Kimura S, Nakamura Y, Kobayashi N, Shiroguchi K, Kawakami E, Mutoh M, et al. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity. Nat Commun. 2020;11:234 pubmed publisher
  55. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  56. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  57. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  58. Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher
  59. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed publisher
  60. Tsao L, Crosby E, Trotter T, Agarwal P, Hwang B, Acharya C, et al. CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis. JCI Insight. 2019;4: pubmed publisher
  61. Reed M, Luissint A, Azcutia V, Fan S, O Leary M, Quirós M, et al. Epithelial CD47 is critical for mucosal repair in the murine intestine in vivo. Nat Commun. 2019;10:5004 pubmed publisher
  62. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  63. Constantinides M, Link V, Tamoutounour S, Wong A, Pérez Chaparro P, Han S, et al. MAIT cells are imprinted by the microbiota in early life and promote tissue repair. Science. 2019;366: pubmed publisher
  64. Lin F, Meng X, Guo Y, Cao W, Liu W, Xia Q, et al. Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1. Sci Adv. 2019;5:eaax1608 pubmed publisher
  65. Helsley R, Varadharajan V, Brown A, Gromovsky A, Schugar R, Ramachandiran I, et al. Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. elife. 2019;8: pubmed publisher
  66. Mani V, Bromley S, Aijö T, Mora Buch R, Carrizosa E, Warner R, et al. Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate. Science. 2019;366: pubmed publisher
  67. Nelson C, Thompson E, Quarnstrom C, Fraser K, Seelig D, Bhela S, et al. Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens. Cell Rep. 2019;28:3092-3104.e5 pubmed publisher
  68. Schreiber L, Urbiola C, Das K, Spiesschaert B, Kimpel J, Heinemann F, et al. The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer. Br J Cancer. 2019;121:647-658 pubmed publisher
  69. Liu Z, Gu Y, Chakarov S, Blériot C, Kwok I, Chen X, et al. Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells. Cell. 2019;178:1509-1525.e19 pubmed publisher
  70. Zhang F, Parayath N, Ene C, Stephan S, Koehne A, Coon M, et al. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat Commun. 2019;10:3974 pubmed publisher
  71. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  72. Rosshart S, Herz J, Vassallo B, Hunter A, Wall M, Badger J, et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science. 2019;365: pubmed publisher
  73. Ma L, Dichwalkar T, Chang J, Cossette B, Garafola D, Zhang A, et al. Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor. Science. 2019;365:162-168 pubmed publisher
  74. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  75. Leach S, Shinnakasu R, Adachi Y, Momota M, Makino Okamura C, Yamamoto T, et al. Requirement for memory B cell activation in protection from heterologous influenza virus reinfection. Int Immunol. 2019;: pubmed publisher
  76. Ansaldo E, Slayden L, Ching K, Koch M, Wolf N, Plichta D, et al. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 2019;364:1179-1184 pubmed publisher
  77. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  78. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  79. Wilkinson A, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo R, et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature. 2019;: pubmed publisher
  80. Rühl J, Citterio C, Engelmann C, Haigh T, Dzionek A, Dreyer J, et al. Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas. J Clin Invest. 2019;129:2071-2087 pubmed publisher
  81. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  82. Esterházy D, Canesso M, Mesin L, Muller P, de Castro T, Lockhart A, et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature. 2019;569:126-130 pubmed publisher
  83. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  84. Lytle N, Ferguson L, Rajbhandari N, Gilroy K, Fox R, Deshpande A, et al. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Cell. 2019;177:572-586.e22 pubmed publisher
  85. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  86. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  87. Thompson P, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metab. 2019;29:1045-1060.e10 pubmed publisher
  88. Anandagoda N, Willis J, Hertweck A, Roberts L, Jackson I, Gökmen M, et al. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance. J Clin Invest. 2019;129:1257-1271 pubmed publisher
  89. Salerno F, Guislain A, Freen van Heeren J, Nicolet B, Young H, Wolkers M. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells. Oncoimmunology. 2019;8:e1532762 pubmed publisher
  90. Davies A, Kim H, González Cano R, Choi J, Back S, Roh S, et al. Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury. Cell. 2019;176:716-728.e18 pubmed publisher
  91. Lee Y, Ju J, Shon W, Oh S, Min C, Kang M, et al. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD. Immune Netw. 2018;18:e44 pubmed publisher
  92. Li J, He Y, Hao J, Ni L, Dong C. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells. Front Immunol. 2018;9:2981 pubmed publisher
  93. Cornelissen L, Blanas A, van der Horst J, Kruijssen L, Zaal A, O Toole T, et al. Disruption of sialic acid metabolism drives tumor growth by augmenting CD8+ T cell apoptosis. Int J Cancer. 2019;144:2290-2302 pubmed publisher
  94. Chorro L, Suzuki M, Chin S, Williams T, Snapp E, Odagiu L, et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun. 2018;9:5368 pubmed publisher
  95. Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin G, Shurin M, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019;116:1361-1369 pubmed publisher
  96. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  97. Harrison O, Linehan J, Shih H, Bouladoux N, Han S, SMELKINSON M, et al. Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury. Science. 2019;363: pubmed publisher
  98. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  99. Du X, de Almeida P, Manieri N, de Almeida Nagata D, Wu T, Harden Bowles K, et al. CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1. Proc Natl Acad Sci U S A. 2018;115:E11731-E11740 pubmed publisher
  100. Aarts S, Seijkens T, Kusters P, Van Tiel C, Reiche M, den Toom M, et al. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. J Pathol. 2019;247:471-480 pubmed publisher
  101. He Z, Zhang J, Huang Z, Du Q, Li N, Zhang Q, et al. Sumoylation of RORγt regulates TH17 differentiation and thymocyte development. Nat Commun. 2018;9:4870 pubmed publisher
  102. Wilgenburg B, Loh L, Chen Z, Pediongco T, Wang H, Shi M, et al. MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun. 2018;9:4706 pubmed publisher
  103. Zhang C, Jiang M, Zhou H, Liu W, Wang C, Kang Z, et al. TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation. J Clin Invest. 2018;128:5399-5412 pubmed publisher
  104. Bhagwandin C, Ashbeck E, Whalen M, Bandola Simon J, Roche P, Szajman A, et al. The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner. PLoS ONE. 2018;13:e0204898 pubmed publisher
  105. Sheng C, Yao C, Wang Z, Chen H, Zhao Y, Xu D, et al. Cyclophilin J limits inflammation through the blockage of ubiquitin chain sensing. Nat Commun. 2018;9:4381 pubmed publisher
  106. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  107. Er J, Koean R, Ding J. Loss of T-bet confers survival advantage to influenza-bacterial superinfection. EMBO J. 2019;38: pubmed publisher
  108. Luo H, Winkelmann E, Zhu S, Ru W, Mays E, Silvas J, et al. Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection. J Clin Invest. 2018;128:4980-4991 pubmed publisher
  109. Lin Y, Wang L, Lee C, Chen S. Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses. Sci Rep. 2018;8:12184 pubmed publisher
  110. Zhao D, Kim Y, Jeong S, Greenson J, Chaudhry M, Hoepting M, et al. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018;128:4970-4979 pubmed publisher
  111. Poffenberger M, Metcalfe Roach A, Aguilar E, Chen J, Hsu B, Wong A, et al. LKB1 deficiency in T cells promotes the development of gastrointestinal polyposis. Science. 2018;361:406-411 pubmed publisher
  112. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  113. Thyagarajan H, Lancaster J, Lira S, Ehrlich L. CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction. PLoS ONE. 2018;13:e0200765 pubmed publisher
  114. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  115. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  116. Cho S, Lee H, Yu I, Choi Y, Huang H, Hashemifar S, et al. Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun. 2018;9:2757 pubmed publisher
  117. Tan B, Shi X, Zhang J, Qin J, Zhang N, Ren H, et al. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization. Cancer Res. 2018;78:4929-4942 pubmed publisher
  118. Kirkling M, Cytlak U, Lau C, Lewis K, Resteu A, Khodadadi Jamayran A, et al. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep. 2018;23:3658-3672.e6 pubmed publisher
  119. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  120. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed publisher
  121. Kanneganti A, Malireddi R, Saavedra P, Vande Walle L, Van Gorp H, Kambara H, et al. GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever. J Exp Med. 2018;215:1519-1529 pubmed publisher
  122. Drobek A, Moudra A, Mueller D, Huranová M, Horková V, Pribikova M, et al. Strong homeostatic TCR signals induce formation of self-tolerant virtual memory CD8 T cells. EMBO J. 2018;37: pubmed publisher
  123. Crosby E, Wei J, Yang X, Lei G, Wang T, Liu C, et al. Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors. Oncoimmunology. 2018;7:e1421891 pubmed publisher
  124. Ubil E, Caskey L, Holtzhausen A, Hunter D, Story C, Earp H. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. J Clin Invest. 2018;128:2356-2369 pubmed publisher
  125. Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari Mimoun C, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci U S A. 2018;115:E4041-E4050 pubmed publisher
  126. Ferrari de Andrade L, Tay R, Pan D, Luoma A, Ito Y, Badrinath S, et al. Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity. Science. 2018;359:1537-1542 pubmed publisher
  127. Harker J, Wong K, Dallari S, Bao P, Dolgoter A, Jo Y, et al. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection. J Virol. 2018;92: pubmed publisher
  128. Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine T, et al. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest. 2018;128:2487-2499 pubmed publisher
  129. Xi J, Huang Q, Wang L, Ma X, Deng Q, Kumar M, et al. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy. Oncogene. 2018;37:3151-3165 pubmed publisher
  130. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  131. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  132. A Verghese D, Demir M, Chun N, Fribourg M, Cravedi P, Llaudó I, et al. T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival. J Immunol. 2018;200:2186-2198 pubmed publisher
  133. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed publisher
  134. Liang W, Mao S, Sun S, Li M, Li Z, Yu R, et al. Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation. Front Immunol. 2018;9:78 pubmed publisher
  135. Mathew N, Baumgartner F, Braun L, O Sullivan D, Thomas S, Waterhouse M, et al. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018;24:282-291 pubmed publisher
  136. King E, Mazor R, Cuburu N, Pastan I. Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin. J Immunol. 2018;200:2038-2045 pubmed publisher
  137. Böttcher J, Bonavita E, Chakravarty P, Blees H, Cabeza Cabrerizo M, Sammicheli S, et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell. 2018;172:1022-1037.e14 pubmed publisher
  138. Ellestad K, Thangavelu G, Haile Y, Lin J, Boon L, Anderson C. Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1. Front Immunol. 2018;9:12 pubmed publisher
  139. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed publisher
  140. Scott J, Lebratti T, Richner J, Jiang X, Fernandez E, Zhao H, et al. Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice. J Virol. 2018;92: pubmed publisher
  141. Tang H, Liang Y, Anders R, Taube J, Qiu X, Mulgaonkar A, et al. PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. J Clin Invest. 2018;128:580-588 pubmed publisher
  142. Tavazoie M, Pollack I, Tanqueco R, Ostendorf B, Reis B, Gonsalves F, et al. LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer. Cell. 2018;172:825-840.e18 pubmed publisher
  143. Christ A, Günther P, Lauterbach M, Duewell P, Biswas D, Pelka K, et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell. 2018;172:162-175.e14 pubmed publisher
  144. Mazor R, King E, Onda M, Cuburu N, Addissie S, Crown D, et al. Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity. Proc Natl Acad Sci U S A. 2018;115:E733-E742 pubmed publisher
  145. Guarnerio J, Mendez L, Asada N, Menon A, Fung J, Berry K, et al. A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche. Nat Commun. 2018;9:66 pubmed publisher
  146. Burrack A, Malhotra D, Dileepan T, Osum K, Swanson L, Fife B, et al. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol. 2018;200:477-482 pubmed publisher
  147. Medaglia C, Giladi A, Stoler Barak L, De Giovanni M, Salame T, Biram A, et al. Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq. Science. 2017;358:1622-1626 pubmed publisher
  148. Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14 pubmed publisher
  149. Ernszt D, Banfai K, Kellermayer Z, Pap A, Lord J, Pongracz J, et al. PPARgamma Deficiency Counteracts Thymic Senescence. Front Immunol. 2017;8:1515 pubmed publisher
  150. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  151. Mao A, Ishizuka I, Kasal D, Mandal M, Bendelac A. A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development. Nat Commun. 2017;8:863 pubmed publisher
  152. Danahy D, Anthony S, Jensen I, Hartwig S, Shan Q, Xue H, et al. Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells. PLoS Pathog. 2017;13:e1006569 pubmed publisher
  153. Koyanagi N, Imai T, Shindo K, Sato A, Fujii W, Ichinohe T, et al. Herpes simplex virus-1 evasion of CD8+ T cell accumulation contributes to viral encephalitis. J Clin Invest. 2017;127:3784-3795 pubmed publisher
  154. Wang Y, Yun C, Gao B, Xu Y, Zhang Y, Wang Y, et al. The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation. Cell Rep. 2017;20:600-612 pubmed publisher
  155. Alloatti A, Rookhuizen D, Joannas L, Carpier J, Iborra S, Magalhaes J, et al. Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity. J Exp Med. 2017;214:2231-2241 pubmed publisher
  156. Hannibal T, Schmidt Christensen A, Nilsson J, Fransén Pettersson N, Hansen L, Holmberg D. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice. Diabetologia. 2017;60:2033-2041 pubmed publisher
  157. Mildner A, Schönheit J, Giladi A, David E, Lara Astiaso D, Lorenzo Vivas E, et al. Genomic Characterization of Murine Monocytes Reveals C/EBP? Transcription Factor Dependence of Ly6C- Cells. Immunity. 2017;46:849-862.e7 pubmed publisher
  158. Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545:500-504 pubmed publisher
  159. Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran J, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017;545:439-445 pubmed publisher
  160. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  161. Audzevich T, Bashford Rogers R, Mabbott N, Frampton D, Freeman T, Potocnik A, et al. Pre/pro-B cells generate macrophage populations during homeostasis and inflammation. Proc Natl Acad Sci U S A. 2017;114:E3954-E3963 pubmed publisher
  162. Zhang H, Luo J, Alcorn J, Chen K, Fan S, Pilewski J, et al. AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality. J Immunol. 2017;198:4383-4393 pubmed publisher
  163. Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, et al. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med. 2017;214:1471-1491 pubmed publisher
  164. Claser C, de Souza J, Thorburn S, Grau G, Riley E, Renia L, et al. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling. Infect Immun. 2017;85: pubmed publisher
  165. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  166. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  167. Tian L, Goldstein A, Wang H, Ching Lo H, Sun Kim I, Welte T, et al. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017;544:250-254 pubmed publisher
  168. Guo Q, Minnier J, Burchard J, Chiotti K, Spellman P, Schedin P. Physiologically activated mammary fibroblasts promote postpartum mammary cancer. JCI Insight. 2017;2:e89206 pubmed publisher
  169. Thomas D, Clare S, Sowerby J, Pardo M, Juss J, Goulding D, et al. Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. J Exp Med. 2017;214:1111-1128 pubmed publisher
  170. Briseño C, Gargaro M, Durai V, Davidson J, Theisen D, Anderson D, et al. Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A. 2017;114:3957-3962 pubmed publisher
  171. Sindhava V, Oropallo M, Moody K, Naradikian M, Higdon L, Zhou L, et al. A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens. J Clin Invest. 2017;127:1651-1663 pubmed publisher
  172. Klein J, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, et al. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun. 2017;8:14600 pubmed publisher
  173. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  174. Guidi N, Sacma M, Ständker L, Soller K, Marka G, Eiwen K, et al. Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells. EMBO J. 2017;36:840-853 pubmed publisher
  175. Fisher S, Aston W, Chee J, Khong A, Cleaver A, Solin J, et al. Transient Treg depletion enhances therapeutic anti-cancer vaccination. Immun Inflamm Dis. 2017;5:16-28 pubmed publisher
  176. Stanley R, Piszczatowski R, Bartholdy B, Mitchell K, McKimpson W, Narayanagari S, et al. A myeloid tumor suppressor role for NOL3. J Exp Med. 2017;214:753-771 pubmed publisher
  177. Huang A, Peng D, Guo H, Ben Y, Zuo X, Wu F, et al. A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies. Sci Rep. 2017;7:42687 pubmed publisher
  178. Rossey I, Gilman M, Kabeche S, Sedeyn K, Wrapp D, Kanekiyo M, et al. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nat Commun. 2017;8:14158 pubmed publisher
  179. Zamarin D, Holmgaard R, Ricca J, Plitt T, Palese P, Sharma P, et al. Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nat Commun. 2017;8:14340 pubmed publisher
  180. Ying W, Wollam J, Ofrecio J, Bandyopadhyay G, El Ouarrat D, Lee Y, et al. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J Clin Invest. 2017;127:1019-1030 pubmed publisher
  181. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  182. Ramjee V, Li D, Manderfield L, Liu F, Engleka K, Aghajanian H, et al. Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction. J Clin Invest. 2017;127:899-911 pubmed publisher
  183. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  184. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  185. Hattori A, McSkimming D, Kannan N, Ito T. RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia. Leuk Res. 2017;54:47-54 pubmed publisher
  186. Ai J, Li J, Gessler D, Su Q, Wei Q, Li H, et al. Adeno-associated virus serotype rh.10 displays strong muscle tropism following intraperitoneal delivery. Sci Rep. 2017;7:40336 pubmed publisher
  187. Atkin Smith G, Paone S, Zanker D, Duan M, Phan T, Chen W, et al. Isolation of cell type-specific apoptotic bodies by fluorescence-activated cell sorting. Sci Rep. 2017;7:39846 pubmed publisher
  188. Cañete A, Carmona R, Ariza L, Sanchez M, Rojas A, Muñoz Chápuli R. A population of hematopoietic stem cells derives from GATA4-expressing progenitors located in the placenta and lateral mesoderm of mice. Haematologica. 2017;102:647-655 pubmed publisher
  189. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  190. Hayakawa M, Hayakawa H, Petrova T, Ritprajak P, Sutavani R, Jiménez Andrade G, et al. Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. J Biol Chem. 2017;292:1762-1772 pubmed publisher
  191. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed publisher
  192. Karki R, Man S, Malireddi R, Kesavardhana S, Zhu Q, Burton A, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature. 2016;540:583-587 pubmed publisher
  193. Bieber K, Witte M, Sun S, Hundt J, Kalies K, Dräger S, et al. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Sci Rep. 2016;6:38357 pubmed publisher
  194. Ma C, Mishra S, Demel E, Liu Y, Zhang N. TGF-? Controls the Formation of Kidney-Resident T Cells via Promoting Effector T Cell Extravasation. J Immunol. 2017;198:749-756 pubmed publisher
  195. Muschaweckh A, Buchholz V, Fellenzer A, Hessel C, König P, Tao S, et al. Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+ T cells. J Exp Med. 2016;213:3075-3086 pubmed
  196. Kuchmiy A, D Hont J, Hochepied T, Lamkanfi M. NLRP2 controls age-associated maternal fertility. J Exp Med. 2016;213:2851-2860 pubmed
  197. Theisen E, Sauer J. Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity. Infect Immun. 2017;85: pubmed publisher
  198. Shirakawa K, Yan X, Shinmura K, Endo J, Kataoka M, Katsumata Y, et al. Obesity accelerates T cell senescence in murine visceral adipose tissue. J Clin Invest. 2016;126:4626-4639 pubmed publisher
  199. Zamora Pineda J, Kumar A, Suh J, Zhang M, Saba J. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. J Exp Med. 2016;213:2773-2791 pubmed
  200. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  201. Theeß W, Sellau J, Steeg C, Klinke A, Baldus S, Cramer J, et al. Myeloperoxidase Attenuates Pathogen Clearance during Plasmodium yoelii Nonlethal Infection. Infect Immun. 2017;85: pubmed publisher
  202. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  203. Zhao J, Chen C, Guo M, Tao Y, Cui P, Zhou Y, et al. MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4. Front Immunol. 2016;7:389 pubmed
  204. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed publisher
  205. Clement M, Pearson J, Gras S, van den Berg H, Lissina A, Llewellyn Lacey S, et al. Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies. Sci Rep. 2016;6:35332 pubmed publisher
  206. Alves da Costa T, Di Gangi R, Thomé R, Barreto Felisbino M, Pires Bonfanti A, Lumi Watanabe Ishikawa L, et al. Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis. PLoS ONE. 2016;11:e0164745 pubmed publisher
  207. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  208. Lopez Guadamillas E, Fernandez Marcos P, Pantoja C, Muñoz Martin M, Martinez D, Gomez Lopez G, et al. p21Cip1 plays a critical role in the physiological adaptation to fasting through activation of PPAR?. Sci Rep. 2016;6:34542 pubmed publisher
  209. Johnston L, Hsu C, Krier Burris R, Chhiba K, Chien K, McKenzie A, et al. IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis. J Immunol. 2016;197:3445-3453 pubmed
  210. Arunachalam P, Mishra R, Badarinath K, Selvam D, Payeli S, Stout R, et al. Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination. Sci Rep. 2016;6:33564 pubmed publisher
  211. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  212. Takeshima T, Pop L, Laine A, Iyengar P, Vitetta E, Hannan R. Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF. Proc Natl Acad Sci U S A. 2016;113:11300-11305 pubmed
  213. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  214. Hirai Yuki A, Hensley L, McGivern D, Gonzalez Lopez O, Das A, Feng H, et al. MAVS-dependent host species range and pathogenicity of human hepatitis A virus. Science. 2016;353:1541-1545 pubmed
  215. Hu H, Umemori H, Hsueh Y. Postsynaptic SDC2 induces transsynaptic signaling via FGF22 for bidirectional synaptic formation. Sci Rep. 2016;6:33592 pubmed publisher
  216. Bernard Valnet R, Yshii L, Quériault C, Nguyen X, Arthaud S, Rodrigues M, et al. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci U S A. 2016;113:10956-61 pubmed publisher
  217. Saranchova I, Han J, Huang H, Fenninger F, Choi K, Munro L, et al. Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33. Sci Rep. 2016;6:30555 pubmed publisher
  218. Akk A, Springer L, Pham C. Neutrophil Extracellular Traps Enhance Early Inflammatory Response in Sendai Virus-Induced Asthma Phenotype. Front Immunol. 2016;7:325 pubmed publisher
  219. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  220. Zhang S, Liu X, Mei L, Wang H, Fang F. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice. BMC Complement Altern Med. 2016;16:334 pubmed publisher
  221. Uckelmann H, Blaszkiewicz S, Nicolae C, Haas S, Schnell A, Wurzer S, et al. Extracellular matrix protein Matrilin-4 regulates stress-induced HSC proliferation via CXCR4. J Exp Med. 2016;213:1961-71 pubmed publisher
  222. Fabbiano S, Suárez Zamorano N, Rigo D, Veyrat Durebex C, Stevanovic Dokic A, Colin D, et al. Caloric Restriction Leads to Browning of White Adipose Tissue through Type 2 Immune Signaling. Cell Metab. 2016;24:434-446 pubmed publisher
  223. Bombeiro A, Thomé R, Oliveira Nunes S, Monteiro Moreira B, Verinaud L, Oliveira A. MHC-I and PirB Upregulation in the Central and Peripheral Nervous System following Sciatic Nerve Injury. PLoS ONE. 2016;11:e0161463 pubmed publisher
  224. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  225. He C, Duan X, Guo N, Chan C, Poon C, Weichselbaum R, et al. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun. 2016;7:12499 pubmed publisher
  226. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed publisher
  227. Meliopoulos V, Van De Velde L, Van De Velde N, Karlsson E, Neale G, Vogel P, et al. An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens. PLoS Pathog. 2016;12:e1005804 pubmed publisher
  228. Carow B, Gao Y, Coquet J, Reilly M, Rottenberg M. lck-Driven Cre Expression Alters T Cell Development in the Thymus and the Frequencies and Functions of Peripheral T Cell Subsets. J Immunol. 2016;197:2261-8 pubmed publisher
  229. You L, Li L, Zou J, Yan K, Belle J, Nijnik A, et al. BRPF1 is essential for development of fetal hematopoietic stem cells. J Clin Invest. 2016;126:3247-62 pubmed publisher
  230. Shi Y, Wu W, Chai Q, Li Q, Hou Y, Xia H, et al. LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016;7:12369 pubmed publisher
  231. Imhof B, Jemelin S, Ballet R, Vesin C, Schapira M, Karaca M, et al. CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation. Proc Natl Acad Sci U S A. 2016;113:E4847-56 pubmed publisher
  232. Hwang S, Cobb D, Bhadra R, Youngblood B, Khan I. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med. 2016;213:1799-818 pubmed publisher
  233. Seifert A, Zeng S, Zhang J, Kim T, Cohen N, Beckman M, et al. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin Cancer Res. 2017;23:454-465 pubmed publisher
  234. Chen S, Miyazaki M, Chandra V, Fisch K, Chang A, Murre C. Id3 Orchestrates Germinal Center B Cell Development. Mol Cell Biol. 2016;36:2543-52 pubmed publisher
  235. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  236. Stifter K, Schuster C, Schlosser M, Boehm B, Schirmbeck R. Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination. Sci Rep. 2016;6:29419 pubmed publisher
  237. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed publisher
  238. Keil M, Sonner J, Lanz T, Oezen I, Bunse T, Bittner S, et al. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. J Neuroimmunol. 2016;297:117-26 pubmed publisher
  239. Gorman M, Poddar S, Farzan M, Diamond M. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis. J Virol. 2016;90:8212-25 pubmed publisher
  240. Bombeiro A, Santini J, Thomé R, Ferreira E, Nunes S, Moreira B, et al. Enhanced Immune Response in Immunodeficient Mice Improves Peripheral Nerve Regeneration Following Axotomy. Front Cell Neurosci. 2016;10:151 pubmed publisher
  241. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed publisher
  242. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  243. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  244. Albarrán Juárez J, Kaur H, Grimm M, Offermanns S, Wettschureck N. Lineage tracing of cells involved in atherosclerosis. Atherosclerosis. 2016;251:445-453 pubmed publisher
  245. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed publisher
  246. Stentzel S, Teufelberger A, Nordengrün M, Kolata J, Schmidt F, Van Crombruggen K, et al. Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus. J Allergy Clin Immunol. 2017;139:492-500.e8 pubmed publisher
  247. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  248. Mkhikian H, Mortales C, Zhou R, Khachikyan K, Wu G, Haslam S, et al. Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis. elife. 2016;5: pubmed publisher
  249. Sujino T, London M, Hoytema van Konijnenburg D, Rendon T, Buch T, Silva H, et al. Tissue adaptation of regulatory and intraepithelial CD4? T cells controls gut inflammation. Science. 2016;352:1581-6 pubmed publisher
  250. Seehus C, Kaye J. In vitro Differentiation of Murine Innate Lymphoid Cells from Common Lymphoid Progenitor Cells. Bio Protoc. 2016;6: pubmed
  251. Stein S, Mack E, Rome K, Pajcini K, Ohtani T, Xu L, et al. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL. PLoS ONE. 2016;11:e0155408 pubmed publisher
  252. Brandstätter O, Schanz O, Vorac J, König J, Mori T, Maruyama T, et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep. 2016;6:26091 pubmed publisher
  253. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  254. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  255. Reynaldi A, Smith N, Schlub T, Venturi V, Rudd B, Davenport M. Modeling the dynamics of neonatal CD8+ T-cell responses. Immunol Cell Biol. 2016;94:838-848 pubmed publisher
  256. Szalay G, Martinecz B, Lénárt N, Kornyei Z, Orsolits B, Judák L, et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499 pubmed publisher
  257. Pietras E, Mirantes Barbeito C, Fong S, Loeffler D, Kovtonyuk L, Zhang S, et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016;18:607-18 pubmed publisher
  258. Carofino B, Ayanga B, Tracey L, Brooke Bisschop T, Justice M. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biol Open. 2016;5:645-53 pubmed publisher
  259. Verbist K, Guy C, Milasta S, Liedmann S, Kaminski M, Wang R, et al. Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature. 2016;532:389-93 pubmed publisher
  260. Lee S, Hong S, Verma V, Lee Y, Duong T, Jeong K, et al. Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer. Oncoimmunology. 2016;5:e1081328 pubmed
  261. Du C, Duan Y, Wei W, Cai Y, Chai H, Lv J, et al. Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination. Nat Commun. 2016;7:11120 pubmed publisher
  262. Braun J, Meixner A, Brachner A, Foisner R. The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis. PLoS ONE. 2016;11:e0152278 pubmed publisher
  263. Qi X, Gurung P, Malireddi R, Karmaus P, Sharma D, Vogel P, et al. Critical role of caspase-8-mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis. Mucosal Immunol. 2017;10:128-138 pubmed publisher
  264. Martin B, Wang C, Zhang C, Kang Z, Gulen M, Zepp J, et al. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis. Nat Immunol. 2016;17:583-92 pubmed publisher
  265. Chattopadhyay A, Navab M, Hough G, Grijalva V, Mukherjee P, Fogelman H, et al. Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD. J Lipid Res. 2016;57:832-47 pubmed publisher
  266. Miller M, Blystone S. Human Macrophages Utilize the Podosome Formin FMNL1 for Adhesion and Migration. Cellbio (Irvine, Calif). 2015;4:1-11 pubmed
  267. Marek I, Lichtneger T, Cordasic N, Hilgers K, Volkert G, Fahlbusch F, et al. Alpha8 Integrin (Itga8) Signalling Attenuates Chronic Renal Interstitial Fibrosis by Reducing Fibroblast Activation, Not by Interfering with Regulation of Cell Turnover. PLoS ONE. 2016;11:e0150471 pubmed publisher
  268. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  269. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  270. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  271. Azpilikueta A, Agorreta J, Labiano S, Pérez Gracia J, Sánchez Paulete A, Aznar M, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016;11:524-36 pubmed publisher
  272. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  273. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  274. Masuda T, Wang X, Maeda M, Canver M, Sher F, Funnell A, et al. Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. Science. 2016;351:285-9 pubmed publisher
  275. Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs M, et al. A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. PLoS Pathog. 2016;12:e1005410 pubmed publisher
  276. Duhan V, Khairnar V, Friedrich S, Zhou F, Gassa A, Honke N, et al. Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral control. Sci Rep. 2016;6:19191 pubmed publisher
  277. Yabas M, Jing W, Shafik S, Bröer S, Enders A. ATP11C Facilitates Phospholipid Translocation across the Plasma Membrane of All Leukocytes. PLoS ONE. 2016;11:e0146774 pubmed publisher
  278. Luchsinger L, de Almeida M, Corrigan D, Mumau M, Snoeck H. Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential. Nature. 2016;529:528-31 pubmed publisher
  279. Gallego Ortega D, Ledger A, Roden D, Law A, Magenau A, Kikhtyak Z, et al. ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells. PLoS Biol. 2015;13:e1002330 pubmed publisher
  280. Everts B, Tussiwand R, Dreesen L, Fairfax K, Huang S, Smith A, et al. Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12. J Exp Med. 2016;213:35-51 pubmed publisher
  281. Ulaganathan V, Sperl B, Rapp U, Ullrich A. Germline variant FGFR4  p.G388R exposes a membrane-proximal STAT3 binding site. Nature. 2015;528:570-4 pubmed publisher
  282. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed publisher
  283. Schachtner H, Weimershaus M, Stache V, Plewa N, Legler D, Höpken U, et al. Loss of Gadkin Affects Dendritic Cell Migration In Vitro. PLoS ONE. 2015;10:e0143883 pubmed publisher
  284. Messaoudi S, He Y, Gutsol A, Wight A, Hébert R, Vilmundarson R, et al. Endothelial Gata5 transcription factor regulates blood pressure. Nat Commun. 2015;6:8835 pubmed publisher
  285. Moretto M, Khan I. IL-21 Is Important for Induction of KLRG1+ Effector CD8 T Cells during Acute Intracellular Infection. J Immunol. 2016;196:375-84 pubmed publisher
  286. Ladell K, Hazenberg M, Fitch M, Emson C, McEvoy Hein Asgarian B, Mold J, et al. Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1?: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease. J Immunol. 2015;195:4096-105 pubmed publisher
  287. Murayama M, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, et al. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat Commun. 2015;6:8483 pubmed publisher
  288. Buerger S, Herrmann V, Mundt S, Trautwein N, Groettrup M, Basler M. The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell Selection. J Immunol. 2015;195:4106-16 pubmed publisher
  289. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  290. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  291. Matsuda Y, Wang X, Oishi H, Guan Z, Saito M, Liu M, et al. Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation. Am J Transplant. 2016;16:342-52 pubmed publisher
  292. Boettler T, Schneider D, Cheng Y, Kadoya K, Brandon E, Martinson L, et al. Pancreatic Tissue Transplanted in TheraCyte Encapsulation Devices Is Protected and Prevents Hyperglycemia in a Mouse Model of Immune-Mediated Diabetes. Cell Transplant. 2016;25:609-14 pubmed publisher
  293. Yoon K, Byun S, Kwon E, Hwang S, Chu K, Hiraki M, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science. 2015;349:1261669 pubmed publisher
  294. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed publisher
  295. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  296. Silva O, Crocetti J, Humphries L, Burkhardt J, Miceli M. Discs Large Homolog 1 Splice Variants Regulate p38-Dependent and -Independent Effector Functions in CD8+ T Cells. PLoS ONE. 2015;10:e0133353 pubmed publisher
  297. Lowe K, Navarro Núñez L, Bénézech C, Nayar S, Kingston B, Nieswandt B, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol. 2015;45:2484-93 pubmed publisher
  298. Pérez Girón J, Gómez Medina S, Lüdtke A, Munoz Fontela C. Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity. J Vis Exp. 2015;:e52803 pubmed publisher
  299. Vogel A, Brown D. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol. 2015;6:327 pubmed publisher
  300. Herz J, Johnson K, McGavern D. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 2015;212:1153-69 pubmed publisher
  301. Xu G, Wu H, Zhang J, Li D, Wang Y, Wang Y, et al. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med. 2015;87:15-25 pubmed publisher
  302. Kamimura D, Katsunuma K, Arima Y, Atsumi T, Jiang J, Bando H, et al. KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR. Nat Commun. 2015;6:7474 pubmed publisher
  303. Conde P, Rodriguez M, van der Touw W, Jimenez A, Burns M, Miller J, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42:1143-58 pubmed publisher
  304. Deppisch N, Ruf P, Eissler N, Neff F, Buhmann R, Lindhofer H, et al. Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery. Mol Cancer Ther. 2015;14:1877-83 pubmed publisher
  305. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  306. Huang H, Chan Y, Hui C, Wu J, Wu C, Chen J. Use of tilapia piscidin 3 (TP3) to protect against MRSA infection in mice with skin injuries. Oncotarget. 2015;6:12955-69 pubmed
  307. Peske J, Thompson E, Gemta L, Baylis R, Fu Y, Engelhard V. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114 pubmed publisher
  308. Kato Nagaoka N, Shimada S, Yamakawa Y, Tsujibe S, Naito T, Setoyama H, et al. Enhanced differentiation of intraepithelial lymphocytes in the intestine of polymeric immunoglobulin receptor-deficient mice. Immunology. 2015;146:59-69 pubmed publisher
  309. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  310. Opata M, Carpio V, Ibitokou S, Dillon B, Obiero J, Stephens R. Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells. J Immunol. 2015;194:5346-54 pubmed publisher
  311. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  312. Wan W, Liu Q, Lionakis M, Marino A, Anderson S, Swamydas M, et al. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice. Cardiovasc Res. 2015;106:478-87 pubmed publisher
  313. Rouhani S, Eccles J, Riccardi P, Peske J, Tewalt E, Cohen J, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun. 2015;6:6771 pubmed publisher
  314. Tsou Y, Lin Y, Shao H, Yu S, Wu S, Lin H, et al. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. PLoS Negl Trop Dis. 2015;9:e0003692 pubmed publisher
  315. Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015;7:754-69 pubmed publisher
  316. Lal G, Nakayama Y, Sethi A, Singh A, Burrell B, Kulkarni N, et al. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance. Transplantation. 2015;99:1817-28 pubmed publisher
  317. Napier R, Norris B, Swimm A, Giver C, Harris W, Laval J, et al. Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. PLoS Pathog. 2015;11:e1004770 pubmed publisher
  318. Charlton J, Tsoukatou D, Mamalaki C, Chatzidakis I. Programmed death 1 regulates memory phenotype CD4 T cell accumulation, inhibits expansion of the effector memory phenotype subset and modulates production of effector cytokines. PLoS ONE. 2015;10:e0119200 pubmed publisher
  319. Povinelli B, Kokolus K, Eng J, Dougher C, Curtin L, Capitano M, et al. Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cells. PLoS ONE. 2015;10:e0120078 pubmed publisher
  320. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed publisher
  321. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  322. Pone E, Lam T, Lou Z, Wang R, Chen Y, Liu D, et al. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses. J Immunol. 2015;194:3065-78 pubmed publisher
  323. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  324. Choi E, Park H, Sul O, Rajasekaran M, Yu R, Choi H. Carbon monoxide reverses adipose tissue inflammation and insulin resistance upon loss of ovarian function. Am J Physiol Endocrinol Metab. 2015;308:E621-30 pubmed publisher
  325. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  326. Sell S, Dietz M, Schneider A, Holtappels R, Mach M, Winkler T. Control of murine cytomegalovirus infection by γδ T cells. PLoS Pathog. 2015;11:e1004481 pubmed publisher
  327. Hu W, Dooley J, Chung S, Chandramohan D, Cimmino L, Mukherjee S, et al. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a. Blood. 2015;125:2206-16 pubmed publisher
  328. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  329. Jing W, Gershan J, Weber J, Tlomak D, McOlash L, Sabatos Peyton C, et al. Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma. J Immunother Cancer. 2015;3:2 pubmed publisher
  330. Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet A, et al. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J Exp Med. 2015;212:139-48 pubmed publisher
  331. Bergot A, Monnet N, Le Tran S, Mittal D, Al Kouba J, Steptoe R, et al. HPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions. Immunol Cell Biol. 2015;93:540-7 pubmed publisher
  332. Sun C, Schattgen S, Pisitkun P, Jorgensen J, Hilterbrand A, Wang L, et al. Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection. J Immunol. 2015;194:1819-31 pubmed publisher
  333. Liu Z, Zhao S, Chen Q, Yan K, Liu P, Li N, et al. Roles of Toll-like receptors 2 and 4 in mediating experimental autoimmune orchitis induction in mice. Biol Reprod. 2015;92:63 pubmed publisher
  334. Spada R, Rojas J, Pérez Yagüe S, Mulens V, Cannata Ortiz P, Bragado R, et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J Leukoc Biol. 2015;97:583-98 pubmed publisher
  335. Sullivan B, Teijaro J, de la Torre J, Oldstone M. Early virus-host interactions dictate the course of a persistent infection. PLoS Pathog. 2015;11:e1004588 pubmed publisher
  336. Sakaguchi S, Hombauer M, Hassan H, Tanaka H, Yasmin N, Naoe Y, et al. A novel Cd8-cis-regulatory element preferentially directs expression in CD44hiCD62L+ CD8+ T cells and in CD8αα+ dendritic cells. J Leukoc Biol. 2015;97:635-44 pubmed publisher
  337. Hu Z, Molloy M, Usherwood E. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose. Cell Mol Immunol. 2016;13:82-93 pubmed publisher
  338. Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE. 2014;9:e115198 pubmed publisher
  339. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed publisher
  340. Karamitros D, Patmanidi A, Kotantaki P, Potocnik A, Bähr Ivacevic T, Benes V, et al. Geminin deletion increases the number of fetal hematopoietic stem cells by affecting the expression of key transcription factors. Development. 2015;142:70-81 pubmed publisher
  341. Harmon E, Fronhofer V, Keller R, Feustel P, Zhu X, Xu H, et al. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques. J Am Heart Assoc. 2014;3:e001232 pubmed publisher
  342. Kim J, Li W, Choi Y, Lewin S, Verbeke C, Dranoff G, et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33:64-72 pubmed publisher
  343. Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, et al. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell Cycle. 2014;13:3670-84 pubmed publisher
  344. Nacer A, Movila A, Sohet F, Girgis N, Gundra U, Loke P, et al. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. PLoS Pathog. 2014;10:e1004528 pubmed publisher
  345. Kobold S, Steffen J, Chaloupka M, Grassmann S, Henkel J, Castoldi R, et al. Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer. J Natl Cancer Inst. 2015;107:364 pubmed publisher
  346. van Blijswijk J, Schraml B, Rogers N, Whitney P, Zelenay S, Acton S, et al. Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells. J Immunol. 2015;194:307-15 pubmed publisher
  347. Baptista A, Roozendaal R, Reijmers R, Koning J, Unger W, Greuter M, et al. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. elife. 2014;3: pubmed publisher
  348. Buchan S, Manzo T, Flutter B, Rogel A, Edwards N, Zhang L, et al. OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence. J Immunol. 2015;194:125-133 pubmed publisher
  349. Schwartz C, Turqueti Neves A, Hartmann S, Yu P, Nimmerjahn F, Voehringer D. Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion. Proc Natl Acad Sci U S A. 2014;111:E5169-77 pubmed publisher
  350. Jurkin J, Henkel T, Nielsen A, Minnich M, Popow J, Kaufmann T, et al. The mammalian tRNA ligase complex mediates splicing of XBP1 mRNA and controls antibody secretion in plasma cells. EMBO J. 2014;33:2922-36 pubmed publisher
  351. Mouchacca P, Chasson L, Frick M, Foray C, Schmitt Verhulst A, Boyer C. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes. Immunology. 2015;145:24-33 pubmed publisher
  352. Backer R, Helbig C, Gentek R, Kent A, Laidlaw B, Dominguez C, et al. A central role for Notch in effector CD8(+) T cell differentiation. Nat Immunol. 2014;15:1143-51 pubmed publisher
  353. Hoelzinger D, Dominguez A, Cohen P, Gendler S. Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges. Cancer Res. 2014;74:6845-55 pubmed publisher
  354. Bertin S, Lozano Ruiz B, Bachiller V, García Martínez I, Herdman S, Zapater P, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015;8:505-15 pubmed publisher
  355. Castro Rojas C, Deason K, Hussain R, Hayardeny L, Cravens P, Yarovinsky F, et al. Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance. J Neuroimmunol. 2014;276:232-5 pubmed publisher
  356. Wei F, Yang D, Tewary P, Li Y, Li S, Chen X, et al. The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant. Cancer Res. 2014;74:5989-98 pubmed publisher
  357. Herranz D, Ambesi Impiombato A, Palomero T, Schnell S, Belver L, Wendorff A, et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med. 2014;20:1130-7 pubmed publisher
  358. Meraz I, Savage D, Segura Ibarra V, Li J, Rhudy J, Gu J, et al. Adjuvant cationic liposomes presenting MPL and IL-12 induce cell death, suppress tumor growth, and alter the cellular phenotype of tumors in a murine model of breast cancer. Mol Pharm. 2014;11:3484-91 pubmed publisher
  359. Dai M, Yip Y, Hellstrom I, Hellstrom K. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015;21:1127-38 pubmed publisher
  360. Rauen J, Kreer C, Paillard A, van Duikeren S, Benckhuijsen W, Camps M, et al. Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PLoS ONE. 2014;9:e103755 pubmed publisher
  361. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  362. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  363. Reeh K, Cardenas K, Bain V, Liu Z, LAURENT M, Manley N, et al. Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis. Development. 2014;141:2950-8 pubmed publisher
  364. Boding L, Hansen A, Meroni G, Johansen B, Braunstein T, Bonefeld C, et al. Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells. Eur J Immunol. 2014;44:3109-18 pubmed publisher
  365. Knoop K, McDonald K, McCrate S, McDole J, Newberry R. Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon. Mucosal Immunol. 2015;8:198-210 pubmed publisher
  366. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  367. Cowan J, McCarthy N, Parnell S, White A, Bacon A, Serge A, et al. Differential requirement for CCR4 and CCR7 during the development of innate and adaptive ??T cells in the adult thymus. J Immunol. 2014;193:1204-12 pubmed publisher
  368. Au Yeung B, Melichar H, Ross J, Cheng D, Zikherman J, Shokat K, et al. Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development. Nat Immunol. 2014;15:687-94 pubmed publisher
  369. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258-69 pubmed publisher
  370. Alsadeq A, Hobeika E, Medgyesi D, Kläsener K, Reth M. The role of the Syk/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling. J Immunol. 2014;193:268-76 pubmed publisher
  371. Geem D, Medina Contreras O, McBride M, Newberry R, Koni P, Denning T. Specific microbiota-induced intestinal Th17 differentiation requires MHC class II but not GALT and mesenteric lymph nodes. J Immunol. 2014;193:431-8 pubmed publisher
  372. Sreedharan R, Chen S, Miller M, Haribhai D, Williams C, Van Why S. Mice with an absent stress response are protected against ischemic renal injury. Kidney Int. 2014;86:515-24 pubmed publisher
  373. Smolarchuk C, Zhu L, Chan W, Anderson C. T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol. 2014;44:2263-73 pubmed publisher
  374. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  375. Meraz I, Hearnden C, Liu X, Yang M, Williams L, Savage D, et al. Multivalent presentation of MPL by porous silicon microparticles favors T helper 1 polarization enhancing the anti-tumor efficacy of doxorubicin nanoliposomes. PLoS ONE. 2014;9:e94703 pubmed publisher
  376. Dupont C, Christian D, Selleck E, Pepper M, Leney Greene M, Harms Pritchard G, et al. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 2014;10:e1004047 pubmed publisher
  377. Könnecke I, Serra A, El Khassawna T, Schlundt C, Schell H, Hauser A, et al. T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion. Bone. 2014;64:155-65 pubmed publisher
  378. Keswani T, Bhattacharyya A. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii. Exp Parasitol. 2014;141:82-92 pubmed publisher
  379. Koga T, Hedrich C, Mizui M, Yoshida N, Otomo K, Lieberman L, et al. CaMK4-dependent activation of AKT/mTOR and CREM-? underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124:2234-45 pubmed publisher
  380. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed publisher
  381. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed publisher
  382. Vanoaica L, Richman L, Jaworski M, Darshan D, Luther S, Kühn L. Conditional deletion of ferritin h in mice reduces B and T lymphocyte populations. PLoS ONE. 2014;9:e89270 pubmed publisher
  383. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed publisher
  384. Ataide M, Andrade W, Zamboni D, Wang D, Souza M, Franklin B, et al. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 2014;10:e1003885 pubmed publisher
  385. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed publisher
  386. Joedicke J, Dietze K, Zelinskyy G, Dittmer U. The phenotype and activation status of regulatory T cells during Friend retrovirus infection. Virol Sin. 2014;29:48-60 pubmed publisher
  387. Gaughan A, Wang J, Pelletier R, Nadasdy T, Brodsky S, Roy S, et al. Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts. Am J Transplant. 2014;14:284-94 pubmed publisher
  388. Yang M, Rainone A, Shi X, Fournier S, Zhang J. A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome. Acta Neuropathol Commun. 2014;2:5 pubmed publisher
  389. Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, Daans J, et al. Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain. Cell Transplant. 2015;24:223-33 pubmed publisher
  390. Cavnar M, Zeng S, Kim T, Sorenson E, Ocuin L, Balachandran V, et al. KIT oncogene inhibition drives intratumoral macrophage M2 polarization. J Exp Med. 2013;210:2873-86 pubmed publisher
  391. Murphy K, Erickson J, Johnson C, Seiler C, Bedi J, Hu P, et al. CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma. J Immunol. 2014;192:224-33 pubmed publisher
  392. Borger J, Zamoyska R, Gakamsky D. Proximity of TCR and its CD8 coreceptor controls sensitivity of T cells. Immunol Lett. 2014;157:16-22 pubmed publisher
  393. Griffiths K, Stylianou E, Poyntz H, Betts G, Fletcher H, McShane H. Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice. PLoS ONE. 2013;8:e78312 pubmed publisher
  394. Moriya T, Fukatsu K, Noguchi M, Okamoto K, Murakoshi S, Saitoh D, et al. Intravenous administration of high-dose Paclitaxel reduces gut-associated lymphoid tissue cell number and respiratory immunoglobulin A concentrations in mice. Surg Infect (Larchmt). 2014;15:50-7 pubmed publisher
  395. Schmitt E, Haribhai D, Jeschke J, Co D, Ziegelbauer J, Yan K, et al. Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression. J Immunol. 2013;191:5460-76 pubmed publisher
  396. Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, et al. Inactivation of tumor-specific CD8? CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol. 2013;91:545-55 pubmed publisher
  397. Bittner Eddy P, Fischer L, Costalonga M. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice. Mol Oral Microbiol. 2013;28:452-66 pubmed publisher
  398. Povinelli B, Nemeth M. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells. 2014;32:105-15 pubmed publisher
  399. Fuertbauer E, Zaujec J, Uhrin P, Raab I, Weber M, Schachner H, et al. Thymic medullar conduits-associated podoplanin promotes natural regulatory T cells. Immunol Lett. 2013;154:31-41 pubmed publisher
  400. Pioli P, Dahlem T, Weis J, Weis J. Deletion of Snai2 and Snai3 results in impaired physical development compounded by lymphocyte deficiency. PLoS ONE. 2013;8:e69216 pubmed publisher
  401. Lappalainen S, Tamminen K, Vesikari T, Blazevic V. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum Vaccin Immunother. 2013;9:1991-2001 pubmed publisher
  402. Ke F, Bouillet P, Kaufmann T, Strasser A, Kerr J, Voss A. Consequences of the combined loss of BOK and BAK or BOK and BAX. Cell Death Dis. 2013;4:e650 pubmed publisher
  403. Wu X, Satpathy A, Kc W, Liu P, Murphy T, Murphy K. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE. 2013;8:e64800 pubmed publisher
  404. Cravens P, Kieseier B, Hussain R, Herndon E, Arellano B, Ben L, et al. The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis. J Neuroinflammation. 2013;10:67 pubmed publisher
  405. Mandal M, Donnelly R, Elkabes S, Zhang P, Davini D, David B, et al. Maternal immune stimulation during pregnancy shapes the immunological phenotype of offspring. Brain Behav Immun. 2013;33:33-45 pubmed publisher
  406. Xiao H, Shen H, Liu W, Xiong R, Li P, Meng G, et al. Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy. PLoS ONE. 2013;8:e60173 pubmed publisher
  407. Gerber S, Sedlacek A, Cron K, Murphy S, Frelinger J, Lord E. IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor. Am J Pathol. 2013;182:2345-54 pubmed publisher
  408. Billich A, Baumruker T, Beerli C, Bigaud M, Bruns C, Calzascia T, et al. Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis. PLoS ONE. 2013;8:e59630 pubmed publisher
  409. Zinselmeyer B, Heydari S, Sacristán C, Nayak D, Cammer M, Herz J, et al. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J Exp Med. 2013;210:757-74 pubmed publisher
  410. Vink P, Smout W, Driessen Engels L, de Bruin A, Delsing D, Krajnc Franken M, et al. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS ONE. 2013;8:e57348 pubmed publisher
  411. Gómez Herreros F, Romero Granados R, Zeng Z, Alvarez Quilón A, Quintero C, Ju L, et al. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo. PLoS Genet. 2013;9:e1003226 pubmed publisher
  412. Hogan T, Shuvaev A, Commenges D, Yates A, Callard R, Thiebaut R, et al. Clonally diverse T cell homeostasis is maintained by a common program of cell-cycle control. J Immunol. 2013;190:3985-93 pubmed publisher
  413. Koning J, Kooij G, de Vries H, Nolte M, Mebius R. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol. 2013;4:49 pubmed publisher
  414. Kipari T, Hadoke P, Iqbal J, Man T, Miller E, Coutinho A, et al. 11?-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis. FASEB J. 2013;27:1519-31 pubmed publisher
  415. Diken M, Kreiter S, Selmi A, Tureci O, Sahin U. Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies. Methods Mol Biol. 2013;969:235-46 pubmed publisher
  416. Bergmann H, Yabas M, Short A, Miosge L, Barthel N, Teh C, et al. B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A. J Exp Med. 2013;210:31-40 pubmed publisher
  417. Cevik S, Keskin N, Belkaya S, Ozlu M, Deniz E, Tazebay U, et al. CD81 interacts with the T cell receptor to suppress signaling. PLoS ONE. 2012;7:e50396 pubmed publisher
  418. Oldstone M, Edelmann K, McGavern D, Cruite J, Welch M. Molecular anatomy and number of antigen specific CD8 T cells required to cause type 1 diabetes. PLoS Pathog. 2012;8:e1003044 pubmed publisher
  419. Sag D, Wingender G, Nowyhed H, Wu R, Gebre A, Parks J, et al. ATP-binding cassette transporter G1 intrinsically regulates invariant NKT cell development. J Immunol. 2012;189:5129-38 pubmed publisher
  420. Mathew R, Seiler M, Scanlon S, Mao A, Constantinides M, Bertozzi Villa C, et al. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature. 2012;491:618-21 pubmed publisher
  421. Yassai M, Cooley B, Gorski J. Developmental dynamics of post-selection thymic DN iNKT. PLoS ONE. 2012;7:e43509 pubmed publisher
  422. Pagán A, Pepper M, Chu H, Green J, Jenkins M. CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J Immunol. 2012;189:2909-17 pubmed publisher
  423. Zhang N, Bevan M. TGF-? signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667-73 pubmed publisher
  424. Jenkins C, Shevchuk O, Giambra V, Lam S, Carboni J, Gottardis M, et al. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein. Exp Hematol. 2012;40:715-723.e6 pubmed publisher
  425. Chevrier S, Genton C, Malissen B, Malissen M, Acha Orbea H. Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Front Immunol. 2012;3:27 pubmed publisher
  426. Barral P, Sanchez Nino M, Van Rooijen N, Cerundolo V, Batista F. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J. 2012;31:2378-90 pubmed publisher
  427. Hurez V, Daniel B, Sun L, Liu A, Ludwig S, Kious M, et al. Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice. Cancer Res. 2012;72:2089-99 pubmed publisher
  428. Lumsden J, Nurmukhambetova S, Klein J, Sattabongkot J, Bennett J, Bertholet S, et al. Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice. Vaccine. 2012;30:3311-9 pubmed publisher
  429. Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney N, Schuijs M, et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS ONE. 2012;7:e32371 pubmed publisher
  430. Sun L, Hurez V, Thibodeaux S, Kious M, Liu A, Lin P, et al. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells. Aging Cell. 2012;11:509-19 pubmed publisher
  431. Dutra R, Leite D, Bento A, Manjavachi M, Patrício E, Figueiredo C, et al. The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in mice. PLoS ONE. 2011;6:e27875 pubmed publisher
  432. Salti S, Hammelev E, Grewal J, Reddy S, Zemple S, Grossman W, et al. Granzyme B regulates antiviral CD8+ T cell responses. J Immunol. 2011;187:6301-9 pubmed publisher
  433. Badeaux A, Yang Y, Cardenas K, Vemulapalli V, Chen K, Kusewitt D, et al. Loss of the methyl lysine effector protein PHF20 impacts the expression of genes regulated by the lysine acetyltransferase MOF. J Biol Chem. 2012;287:429-37 pubmed publisher
  434. Wang R, Xie H, Huang Z, Ma J, Fang X, Ding Y, et al. T cell factor 1 regulates thymocyte survival via a RORγt-dependent pathway. J Immunol. 2011;187:5964-73 pubmed publisher
  435. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park J, et al. Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J. 2012;31:366-77 pubmed publisher
  436. Suliman S, Tan J, Xu K, Kousis P, Kowalski P, Chang G, et al. Notch3 is dispensable for thymocyte ?-selection and Notch1-induced T cell leukemogenesis. PLoS ONE. 2011;6:e24937 pubmed publisher
  437. Bunnell T, Burbach B, Shimizu Y, Ervasti J. ?-Actin specifically controls cell growth, migration, and the G-actin pool. Mol Biol Cell. 2011;22:4047-58 pubmed publisher
  438. Ota N, Wong K, Valdez P, Zheng Y, Crellin N, Diehl L, et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol. 2011;12:941-8 pubmed publisher
  439. Kastenmuller W, Gasteiger G, Subramanian N, Sparwasser T, Busch D, Belkaid Y, et al. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol. 2011;187:3186-97 pubmed publisher
  440. Sun J, Sukhova G, Zhang J, Chen H, Sjoberg S, Libby P, et al. Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol. 2012;32:15-23 pubmed publisher
  441. Yan S, Wang L, Liu N, Wang Y, Chu Y. Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol Cell Biol. 2012;90:421-8 pubmed publisher
  442. Clement M, Ladell K, Ekeruche Makinde J, Miles J, Edwards E, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol. 2011;187:654-63 pubmed publisher
  443. Wojno E, Hosken N, Stumhofer J, O Hara A, Mauldin E, Fang Q, et al. A role for IL-27 in limiting T regulatory cell populations. J Immunol. 2011;187:266-73 pubmed publisher
  444. Goldstein J, Balderas R, Marodon G. Continuous activation of the CD122/STAT-5 signaling pathway during selection of antigen-specific regulatory T cells in the murine thymus. PLoS ONE. 2011;6:e19038 pubmed publisher
  445. Zimmerman M, Haskins K, Bradley B, Gilman J, Gamboni Robertson F, Flores S. Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus. J Surg Res. 2011;168:e195-202 pubmed publisher
  446. Gibbert K, Dietze K, Zelinskyy G, Lang K, Barchet W, Kirschning C, et al. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease. J Immunol. 2010;185:6179-89 pubmed publisher
  447. Mandal M, Marzouk A, Donnelly R, Ponzio N. Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav Immun. 2011;25:863-71 pubmed publisher
  448. Weisel F, Appelt U, Schneider A, Horlitz J, Van Rooijen N, Korner H, et al. Unique requirements for reactivation of virus-specific memory B lymphocytes. J Immunol. 2010;185:4011-21 pubmed publisher
  449. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  450. Charles E, Joshi S, Ash J, Fox B, Farris A, Bzik D, et al. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun. 2010;78:3484-92 pubmed publisher
  451. Mohr C, Arapovic J, Mühlbach H, Panzer M, Weyn A, Dölken L, et al. A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination. J Virol. 2010;84:7730-42 pubmed publisher
  452. Böiers C, Buza Vidas N, Jensen C, Pronk C, Kharazi S, Wittmann L, et al. Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development. Blood. 2010;115:5061-8 pubmed publisher
  453. Thompson J, Chu Y, Glass J, Tapp A, Brown S. The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiation. Free Radic Res. 2010;44:529-40 pubmed publisher
  454. Zavitz C, Bauer C, Gaschler G, Fraser K, Strieter R, Hogaboam C, et al. Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza. J Immunol. 2010;184:2001-13 pubmed publisher
  455. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  456. Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G. Myeloid cells contribute to tumor lymphangiogenesis. PLoS ONE. 2009;4:e7067 pubmed publisher
  457. Thompson J, Chu Y, Glass J, Brown S. Absence of IL-23p19 in donor allogeneic cells reduces mortality from acute GVHD. Bone Marrow Transplant. 2010;45:712-22 pubmed publisher
  458. Wu S, Rhee K, Albesiano E, RABIZADEH S, Wu X, Yen H, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016-22 pubmed publisher
  459. Hu X, Shen H, Tian C, Yu H, Zheng G, XuFeng R, et al. Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model. Blood. 2009;114:3783-92 pubmed publisher
  460. Holcmann M, Stoitzner P, Drobits B, Luehrs P, Stingl G, Romani N, et al. Skin inflammation is not sufficient to break tolerance induced against a novel antigen. J Immunol. 2009;183:1133-43 pubmed publisher
  461. Garidou L, Heydari S, Truong P, Brooks D, McGavern D. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection. J Virol. 2009;83:8905-15 pubmed publisher
  462. Ellestad K, Tsutsui S, Noorbakhsh F, Warren K, Yong V, Pittman Q, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol. 2009;183:298-309 pubmed publisher
  463. Seavey M, Mosmann T. Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization. Vaccine. 2009;27:2342-9 pubmed publisher
  464. Schaeffer M, Han S, Chtanova T, van Dooren G, Herzmark P, Chen Y, et al. Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii. J Immunol. 2009;182:6379-93 pubmed publisher
  465. Moon J, Chu H, Hataye J, Pagán A, Pepper M, McLachlan J, et al. Tracking epitope-specific T cells. Nat Protoc. 2009;4:565-81 pubmed publisher
  466. Tseng K, Chung C, H ng W, Wang S. Early infection termination affects number of CD8+ memory T cells and protective capacities in listeria monocytogenes-infected mice upon rechallenge. J Immunol. 2009;182:4590-600 pubmed publisher
  467. Rajasagi N, Kassim S, Kollias C, Zhao X, Chervenak R, Jennings S. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1. J Virol. 2009;83:5256-68 pubmed publisher
  468. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  469. Rogers N, Lees M, Gabriel L, Maniati E, Rose S, Potter P, et al. A defect in Marco expression contributes to systemic lupus erythematosus development via failure to clear apoptotic cells. J Immunol. 2009;182:1982-90 pubmed publisher
  470. Merck E, Voyle R, MacDonald H. Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 effector functions that control tumor growth. J Immunol. 2009;182:183-92 pubmed
  471. Kanwar N, Fayyazi A, Backofen B, Nitsche M, Dressel R, von Mollard G. Thymic alterations in mice deficient for the SNARE protein VAMP8/endobrevin. Cell Tissue Res. 2008;334:227-42 pubmed publisher
  472. Koehn B, Ford M, Ferrer I, Borom K, Gangappa S, Kirk A, et al. PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. J Immunol. 2008;181:5313-22 pubmed
  473. Wells J, Cowled C, Farzaneh F, Noble A. Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity. J Immunol. 2008;181:3422-31 pubmed
  474. Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, Nomura S, et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2008;105:9041-6 pubmed publisher
  475. Waskow C, Liu K, Darrasse Jèze G, Guermonprez P, Ginhoux F, Merad M, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008;9:676-83 pubmed publisher
  476. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S. Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res. 2008;68:2952-60 pubmed publisher
  477. Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, et al. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Invest Ophthalmol Vis Sci. 2008;49:2172-7 pubmed publisher
  478. Sridhar S, Reyes Sandoval A, Draper S, Moore A, Gilbert S, Gao G, et al. Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J Virol. 2008;82:3822-33 pubmed publisher
  479. Ahonen C, Wasiuk A, Fuse S, Turk M, Ernstoff M, Suriawinata A, et al. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 2008;111:3116-25 pubmed publisher
  480. Willoughby J, Costello P, Nicolas R, Robinson N, Stamp G, Powrie F, et al. Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development. J Immunol. 2007;179:6836-44 pubmed
  481. Venanzi E, Gray D, Benoist C, Mathis D. Lymphotoxin pathway and Aire influences on thymic medullary epithelial cells are unconnected. J Immunol. 2007;179:5693-700 pubmed
  482. Tyznik A, Bevan M. The surprising kinetics of the T cell response to live antigenic cells. J Immunol. 2007;179:4988-95 pubmed
  483. Jeannet G, Scheller M, Scarpellino L, Duboux S, Gardiol N, Back J, et al. Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood. 2008;111:142-9 pubmed
  484. Peng J, Kitchen S, West R, Sigler R, Eisenmann K, Alberts A. Myeloproliferative defects following targeting of the Drf1 gene encoding the mammalian diaphanous related formin mDia1. Cancer Res. 2007;67:7565-71 pubmed
  485. Chen X, Vodanovic Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski W. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood. 2007;110:3804-13 pubmed
  486. Moulton R, Mashruwala M, Smith A, Lindsey D, Wetsel R, Haviland D, et al. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice. J Leukoc Biol. 2007;82:956-67 pubmed
  487. Lepenies B, Cramer J, Burchard G, Wagner H, Kirschning C, Jacobs T. Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol. 2008;197:39-44 pubmed
  488. Iwabuchi N, Takahashi N, Xiao J, Miyaji K, Iwatsuki K. In vitro Th1 cytokine-independent Th2 suppressive effects of bifidobacteria. Microbiol Immunol. 2007;51:649-60 pubmed
  489. Kueng H, Leb V, Haiderer D, Raposo G, Thery C, Derdak S, et al. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007;81:8666-76 pubmed
  490. Wu J, Luo L. A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining. Nat Protoc. 2006;1:2110-5 pubmed
  491. Kasler H, Verdin E. Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes. Mol Cell Biol. 2007;27:5184-200 pubmed
  492. Wu J, Luo L. A protocol for mosaic analysis with a repressible cell marker (MARCM) in Drosophila. Nat Protoc. 2006;1:2583-9 pubmed
  493. Hamm S, Heit A, Koffler M, Huster K, Akira S, Busch D, et al. Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo. Int Immunol. 2007;19:297-304 pubmed
  494. de Jersey J, Snelgrove S, Palmer S, Teteris S, Mullbacher A, Miller J, et al. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. Proc Natl Acad Sci U S A. 2007;104:1295-300 pubmed
  495. Hofmann M, Brinkmann V, Zerwes H. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int Immunopharmacol. 2006;6:1902-10 pubmed
  496. Taylor P, Tsoni S, Willment J, Dennehy K, Rosas M, Findon H, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol. 2007;8:31-8 pubmed
  497. Chang S, Wang K, Lu Y, Yang L, Chen W, Lin Y, et al. Characterization of early gamma interferon (IFN-gamma) expression during murine listeriosis: identification of NK1.1+ CD11c+ cells as the primary IFN-gamma-expressing cells. Infect Immun. 2007;75:1167-76 pubmed
  498. Yang Z, Day Y, Toufektsian M, Xu Y, Ramos S, Marshall M, et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation. 2006;114:2056-64 pubmed
  499. McLoughlin R, Solinga R, Rich J, Zaleski K, Cocchiaro J, Risley A, et al. CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci U S A. 2006;103:10408-10413 pubmed publisher
  500. Chapatte L, Ayyoub M, Morel S, Peitrequin A, Lévy N, Servis C, et al. Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses. Cancer Res. 2006;66:5461-8 pubmed
  501. Hofmann M, Zerwes H. Identification of organ-specific T cell populations by analysis of multiparameter flow cytometry data using DNA-chip analysis software. Cytometry A. 2006;69:533-40 pubmed
  502. Irie J, Wu Y, Wicker L, Rainbow D, Nalesnik M, Hirsch R, et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med. 2006;203:1209-19 pubmed
  503. Chapatte L, Colombetti S, Cerottini J, Lévy F. Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors. Cancer Res. 2006;66:1155-60 pubmed
  504. Ola T, Williams N. Protection of non-obese diabetic mice from autoimmune diabetes by Escherichia coli heat-labile enterotoxin B subunit. Immunology. 2006;117:262-70 pubmed
  505. Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski M, et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 2006;107:3600-8 pubmed
  506. Haque A, Easton A, Smith D, O GARRA A, Van Rooijen N, Lertmemongkolchai G, et al. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis. 2006;193:370-9 pubmed
  507. Fukatsu K, Sakamoto S, Hara E, Ueno C, Maeshima Y, Matsumoto I, et al. Gut ischemia-reperfusion affects gut mucosal immunity: a possible mechanism for infectious complications after severe surgical insults. Crit Care Med. 2006;34:182-7 pubmed
  508. Tsunoda I, Kuang L, Kobayashi Warren M, Fujinami R. Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection. J Virol. 2005;79:14640-6 pubmed
  509. Krieg C, Han P, Stone R, Goularte O, Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175:6420-7 pubmed
  510. Lu M, Tayu R, Ikawa T, Masuda K, Matsumoto I, Mugishima H, et al. The earliest thymic progenitors in adults are restricted to T, NK, and dendritic cell lineage and have a potential to form more diverse TCRbeta chains than fetal progenitors. J Immunol. 2005;175:5848-56 pubmed
  511. Garcia Ojeda M, Dejbakhsh Jones S, Chatterjea Matthes D, Mukhopadhyay A, BitMansour A, Weissman I, et al. Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. J Immunol. 2005;175:4363-73 pubmed
  512. Irwin S, Izzo A, Dow S, Skeiky Y, Reed S, Alderson M, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun. 2005;73:5809-16 pubmed
  513. Koyama K. Dendritic cell expansion occurs in mesenteric lymph nodes of B10.BR mice infected with the murine nematode parasite Trichuris muris. Parasitol Res. 2005;97:186-90 pubmed
  514. Rohrbach F, Weth R, Kursar M, Sloots A, Mittrücker H, Wels W. Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity. J Immunol. 2005;174:5481-9 pubmed
  515. Tivol E, Komorowski R, Drobyski W. Emergent autoimmunity in graft-versus-host disease. Blood. 2005;105:4885-91 pubmed
  516. Gray P, Arimilli S, Palmer E, Parks G, Alexander Miller M. Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract. J Virol. 2005;79:3339-49 pubmed
  517. Kohu K, Sato T, Ohno S, Hayashi K, Uchino R, Abe N, et al. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage. J Immunol. 2005;174:2627-36 pubmed
  518. Koneru M, Schaer D, Monu N, Ayala A, Frey A. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function. J Immunol. 2005;174:1830-40 pubmed
  519. Hoffmann P, Kench J, Vondracek A, Kruk E, Daleke D, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393-404 pubmed
  520. Mischenko V, Kapina M, Eruslanov E, Kondratieva E, Lyadova I, Young D, et al. Mycobacterial dissemination and cellular responses after 1-lobe restricted tuberculosis infection of genetically susceptible and resistant mice. J Infect Dis. 2004;190:2137-45 pubmed
  521. Ito F, Li Q, Shreiner A, Okuyama R, Jure Kunkel M, Teitz Tennenbaum S, et al. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines. Cancer Res. 2004;64:8411-9 pubmed
  522. van Santen H, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med. 2004;200:1221-30 pubmed
  523. Zheng S, Jiang J, Shen H, Chen Y. Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol. 2004;173:5652-8 pubmed
  524. Dalton J, Howell G, Pearson J, Scott P, Carding S. Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. J Immunol. 2004;173:3660-7 pubmed
  525. Prockop S, Petrie H. Regulation of thymus size by competition for stromal niches among early T cell progenitors. J Immunol. 2004;173:1604-11 pubmed
  526. Seroogy C, Soares L, Ranheim E, Su L, Holness C, Bloom D, et al. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J Immunol. 2004;173:79-85 pubmed
  527. Mattner J, Wandersee Steinhäuser A, Pahl A, Rollinghoff M, Majeau G, Hochman P, et al. Protection against progressive leishmaniasis by IFN-beta. J Immunol. 2004;172:7574-82 pubmed
  528. Zhang T, He X, Tsang T, Harris D. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function. Cancer Gene Ther. 2004;11:487-96 pubmed
  529. Hequet O, Vocanson M, Saint Mezard P, Kaiserlian D, Nicolas J, Berard F. CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease. Am J Transplant. 2004;4:872-8 pubmed
  530. Yuan Y, Shen H, Franklin D, Scadden D, Cheng T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol. 2004;6:436-42 pubmed
  531. Cabarrocas J, Piaggio E, Zappulla J, Desbois S, Mars L, Lassmann H, et al. A transgenic mouse model for T-cell ignorance of a glial autoantigen. J Autoimmun. 2004;22:179-89 pubmed
  532. Steptoe R, Stankovic S, Lopaticki S, Jones L, Harrison L, Morahan G. Persistence of recipient lymphocytes in NOD mice after irradiation and bone marrow transplantation. J Autoimmun. 2004;22:131-8 pubmed
  533. Ishihara K, Sawa S, Ikushima H, Hirota S, Atsumi T, Kamimura D, et al. The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis. Int Immunol. 2004;16:455-65 pubmed
  534. Chen B, Cui X, Sempowski G, Domen J, Chao N. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004;103:4344-52 pubmed
  535. Schleicher U, Mattner J, Blos M, Schindler H, Rollinghoff M, Karaghiosoff M, et al. Control of Leishmania major in the absence of Tyk2 kinase. Eur J Immunol. 2004;34:519-29 pubmed
  536. Eruslanov E, Majorov K, Orlova M, Mischenko V, Kondratieva T, Apt A, et al. Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge. Clin Exp Immunol. 2004;135:19-28 pubmed
  537. Morin J, Faideau B, Gagnerault M, Lepault F, Boitard C, Boudaly S. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Clin Exp Immunol. 2003;134:388-95 pubmed
  538. Turley S, Poirot L, Hattori M, Benoist C, Mathis D. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med. 2003;198:1527-37 pubmed
  539. Choi E, Chen J, Wooldridge L, Salio M, Lissina A, Lissin N, et al. High avidity antigen-specific CTL identified by CD8-independent tetramer staining. J Immunol. 2003;171:5116-23 pubmed
  540. Chen B, Cui X, Sempowski G, Chao N. Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. Exp Hematol. 2003;31:953-8 pubmed
  541. Lugering A, Kucharzik T, Soler D, Picarella D, Hudson J, Williams I. Lymphoid precursors in intestinal cryptopatches express CCR6 and undergo dysregulated development in the absence of CCR6. J Immunol. 2003;171:2208-15 pubmed
  542. Wang Z, Morelli A, Hackstein H, Kaneko K, Thomson A. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb. Transplantation. 2003;76:562-71 pubmed
  543. Germeraad W, Kawamoto H, Itoi M, Jiang Y, Amagai T, Katsura Y, et al. Development of thymic microenvironments in vitro is oxygen-dependent and requires permanent presence of T-cell progenitors. J Histochem Cytochem. 2003;51:1225-35 pubmed
  544. Richards M, Liu F, Iwasaki H, Akashi K, Link D. Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway. Blood. 2003;102:3562-8 pubmed
  545. Chatterjea Matthes D, Garcia Ojeda M, Dejbakhsh Jones S, Jerabek L, Manz M, Weissman I, et al. Early defect prethymic in bone marrow T cell progenitors in athymic nu/nu mice. J Immunol. 2003;171:1207-15 pubmed
  546. Norris H, Lybarger L, Martin A, Andersen H, Chervenak D, Chervenak R. TCRbeta enhancer activation occurs in some but not all cells with T cell lineage developmental potential. Cell Immunol. 2003;222:164-74 pubmed
  547. Blos M, Schleicher U, Soares Rocha F, Meissner U, Rollinghoff M, Bogdan C. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur J Immunol. 2003;33:1224-34 pubmed
  548. Koyama K. NK1.1+ cell depletion in vivo fails to prevent protection against infection with the murine nematode parasite Trichuris muris. Parasite Immunol. 2002;24:527-33 pubmed
  549. Egan P, Lawlor K, Alexander W, Wicks I. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest. 2003;111:915-24 pubmed
  550. Kawamoto H, Ohmura K, Fujimoto S, Lu M, Ikawa T, Katsura Y. Extensive proliferation of T cell lineage-restricted progenitors in the thymus: an essential process for clonal expression of diverse T cell receptor beta chains. Eur J Immunol. 2003;33:606-15 pubmed
  551. Yamasaki M, Chujo H, Hirao A, Koyanagi N, Okamoto T, Tojo N, et al. Immunoglobulin and cytokine production from spleen lymphocytes is modulated in C57BL/6J mice by dietary cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid. J Nutr. 2003;133:784-8 pubmed
  552. Shinkai K, Mohrs M, Locksley R. Helper T cells regulate type-2 innate immunity in vivo. Nature. 2002;420:825-9 pubmed
  553. Angulo I, Jiménez Díaz M, García Bustos J, Gargallo D, de las Heras F, Muñoz Fernández M, et al. Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production. Cell Immunol. 2002;218:46-58 pubmed
  554. Culley F, Pollott J, Openshaw P. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med. 2002;196:1381-6 pubmed
  555. Hsu S, Wu C, Han J, Lai M. Involvement of p38 mitogen-activated protein kinase in different stages of thymocyte development. Blood. 2003;101:970-6 pubmed
  556. Cawthon A, Alexander Miller M. Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity. J Immunol. 2002;169:3492-8 pubmed
  557. Litvinova E, Maury S, Boyer O, Bruel S, Benard L, Boisserie G, et al. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease. Blood. 2002;100:2020-5 pubmed
  558. Carrithers M, Visintin I, Viret C, Janeway C. Role of genetic background in P selectin-dependent immune surveillance of the central nervous system. J Neuroimmunol. 2002;129:51-7 pubmed
  559. Yu C, Feng M, Shih H, Lai M. Increased p300 expression inhibits glucocorticoid receptor-T-cell receptor antagonism but does not affect thymocyte positive selection. Mol Cell Biol. 2002;22:4556-66 pubmed
  560. Prasad S, Goodnow C. Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo. Int Immunol. 2002;14:677-84 pubmed
  561. Carter R, Campbell I, O Donnel K, Wicks I. Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking. Clin Exp Immunol. 2002;128:44-51 pubmed
  562. Pan L, Hanrahan J, Li J, Hale L, Zhuang Y. An analysis of T cell intrinsic roles of E2A by conditional gene disruption in the thymus. J Immunol. 2002;168:3923-32 pubmed
  563. Walzer T, Arpin C, Beloeil L, Marvel J. Differential in vivo persistence of two subsets of memory phenotype CD8 T cells defined by CD44 and CD122 expression levels. J Immunol. 2002;168:2704-11 pubmed
  564. Martin P, Ruiz S, Del Hoyo G, Anjuere F, Vargas H, López Bravo M, et al. Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood. 2002;99:1282-8 pubmed
  565. Martinez del Hoyo G, Martin P, Arias C, Marín A, Ardavin C. CD8alpha+ dendritic cells originate from the CD8alpha- dendritic cell subset by a maturation process involving CD8alpha, DEC-205, and CD24 up-regulation. Blood. 2002;99:999-1004 pubmed
  566. Grabbe S, Varga G, Beissert S, Steinert M, Pendl G, Seeliger S, et al. Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J Clin Invest. 2002;109:183-92 pubmed
  567. Wu T, Lee J, Lai Y, Hsu J, Tsai C, Lee Y, et al. Reduced expression of Bcl-2 in CD8+ T cells deficient in the IL-15 receptor alpha-chain. J Immunol. 2002;168:705-12 pubmed
  568. Chen B, Cui X, Sempowski G, Gooding M, Liu C, Haynes B, et al. A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution. Blood. 2002;99:364-71 pubmed
  569. O Connell P, Li W, Wang Z, Specht S, Logar A, Thomson A. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts. J Immunol. 2002;168:143-54 pubmed
  570. Das G, Sheridan S, Janeway C. The source of early IFN-gamma that plays a role in Th1 priming. J Immunol. 2001;167:2004-10 pubmed
  571. Roach D, Martin E, Bean A, Rennick D, Briscoe H, Britton W. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand J Immunol. 2001;54:163-70 pubmed
  572. Zhang J, Kabra N, Cado D, Kang C, Winoto A. FADD-deficient T cells exhibit a disaccord in regulation of the cell cycle machinery. J Biol Chem. 2001;276:29815-8 pubmed
  573. Lan F, Zeng D, Huie P, Higgins J, Strober S. Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-alphabeta. Blood. 2001;97:3458-65 pubmed
  574. Radoja S, Saio M, Frey A. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol. 2001;166:6074-83 pubmed
  575. Ohmura K, Kawamoto H, Lu M, Ikawa T, Ozaki S, Nakao K, et al. Immature multipotent hemopoietic progenitors lacking long-term bone marrow-reconstituting activity in the aorta-gonad-mesonephros region of murine day 10 fetuses. J Immunol. 2001;166:3290-6 pubmed
  576. Leite De Moraes M, Hameg A, Pacilio M, Koezuka Y, Taniguchi M, van Kaer L, et al. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol. 2001;166:945-51 pubmed
  577. Shimizu C, Kawamoto H, Yamashita M, Kimura M, Kondou E, Kaneko Y, et al. Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity. Int Immunol. 2001;13:105-17 pubmed
  578. Izeradjene K, Revillard J, Genestier L. Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells. Int Immunol. 2001;13:85-93 pubmed
  579. Hayashi K, Natsume W, Watanabe T, Abe N, Iwai N, Okada H, et al. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells. J Immunol. 2000;165:6816-24 pubmed
  580. Martin P, del Hoyo G, Anjuere F, Ruiz S, Arias C, Marín A, et al. Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(-) and CD8alpha(+) dendritic cells are generated from CD4(low) lymphoid-committed precursors. Blood. 2000;96:2511-9 pubmed
  581. Bauman S, Nichols K, Murphy J. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol. 2000;165:158-67 pubmed
  582. Feng C, Britton W, Palendira U, Groat N, Briscoe H, Bean A. Up-regulation of VCAM-1 and differential expansion of beta integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection. J Immunol. 2000;164:4853-60 pubmed
  583. de Oca R, Buendia A, Del Rio L, Sanchez J, Salinas J, Navarro J. Polymorphonuclear neutrophils are necessary for the recruitment of CD8(+) T cells in the liver in a pregnant mouse model of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection. Infect Immun. 2000;68:1746-51 pubmed
  584. Lepault F, Gagnerault M. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol. 2000;164:240-7 pubmed
  585. Dejbakhsh Jones S, Strober S. Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow. Proc Natl Acad Sci U S A. 1999;96:14493-8 pubmed
  586. Ikawa T, Kawamoto H, Fujimoto S, Katsura Y. Commitment of common T/Natural killer (NK) progenitors to unipotent T and NK progenitors in the murine fetal thymus revealed by a single progenitor assay. J Exp Med. 1999;190:1617-26 pubmed
  587. Ohmura K, Kawamoto H, Fujimoto S, Ozaki S, Nakao K, Katsura Y. Emergence of T, B, and myeloid lineage-committed as well as multipotent hemopoietic progenitors in the aorta-gonad-mesonephros region of day 10 fetuses of the mouse. J Immunol. 1999;163:4788-95 pubmed
  588. Kang J, Coles M, Raulet D. Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. J Exp Med. 1999;190:973-82 pubmed
  589. Pan L, Sato S, Frederick J, Sun X, Zhuang Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol Cell Biol. 1999;19:5969-80 pubmed
  590. Penttilä J, Anttila M, Varkila K, Puolakkainen M, Sarvas M, Makela P, et al. Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology. 1999;97:490-6 pubmed
  591. Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J Immunol. 1999;163:1315-20 pubmed
  592. Deeths M, Kedl R, Mescher M. CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol. 1999;163:102-10 pubmed
  593. Pihlgren M, Arpin C, Walzer T, Tomkowiak M, Thomas A, Marvel J, et al. Memory CD44(int) CD8 T cells show increased proliferative responses and IFN-gamma production following antigenic challenge in vitro. Int Immunol. 1999;11:699-706 pubmed
  594. Masurier C, Pioche Durieu C, Colombo B, Lacave R, Lemoine F, Klatzmann D, et al. Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy. Immunology. 1999;96:569-77 pubmed
  595. Zeng D, Lewis D, Dejbakhsh Jones S, Lan F, Garcia Ojeda M, Sibley R, et al. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med. 1999;189:1073-81 pubmed
  596. Kawamoto H, Ohmura K, Fujimoto S, Katsura Y. Emergence of T cell progenitors without B cell or myeloid differentiation potential at the earliest stage of hematopoiesis in the murine fetal liver. J Immunol. 1999;162:2725-31 pubmed
  597. Clark L, Appleby M, Brunkow M, Wilkinson J, Ziegler S, Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol. 1999;162:2546-54 pubmed
  598. Sasaki T, Kanke Y, Kudoh K, Misawa Y, Shimizu J, Takita T. Effects of dietary docosahexaenoic acid on surface molecules involved in T cell proliferation. Biochim Biophys Acta. 1999;1436:519-30 pubmed
  599. Batteux F, Tourneur L, Trebeden H, Charreire J, Chiocchia G. Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand. J Immunol. 1999;162:603-8 pubmed
  600. Samoilova E, Horton J, Hilliard B, Liu T, Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol. 1998;161:6480-6 pubmed
  601. Bix M, Wang Z, Thiel B, Schork N, Locksley R. Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism. J Exp Med. 1998;188:2289-99 pubmed
  602. Spiekermann G, Nagler Anderson C. Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol. 1998;161:5825-31 pubmed
  603. Ferrero I, Anjuere F, Azcoitia I, Renno T, MacDonald H, Ardavin C. Viral superantigen-induced negative selection of TCR transgenic CD4+ CD8+ thymocytes depends on activation, but not proliferation. Blood. 1998;91:4248-54 pubmed
  604. Guttormsen H, Wetzler L, Finberg R, Kasper D. Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model. Infect Immun. 1998;66:2026-32 pubmed
  605. Contractor N, Bassiri H, Reya T, Park A, Baumgart D, Wasik M, et al. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J Immunol. 1998;160:385-94 pubmed
  606. Salomon B, Cohen J, Masurier C, Klatzmann D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J Immunol. 1998;160:708-17 pubmed
  607. Samoilova E, Horton J, Bassiri H, Zhang H, Linsley P, Carding S, et al. B7 blockade prevents activation-induced cell death of thymocytes. Int Immunol. 1997;9:1663-8 pubmed
  608. Aiba Y, Hirayama F, Ogawa M. Clonal proliferation and cytokine requirement of murine progenitors for natural killer cells. Blood. 1997;89:4005-12 pubmed
  609. Postel Vinay M, de Mello Coelho V, Gagnerault M, Dardenne M. Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology. 1997;138:1816-20 pubmed
  610. Barrat F, Lesourd B, Louise A, Boulouis H, Vincent Naulleau S, Thibault D, et al. Surface antigen expression in spleen cells of C57B1/6 mice during ageing: influence of sex and parity. Clin Exp Immunol. 1997;107:593-600 pubmed
  611. Lin K, Abraham K. Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway. Int Immunol. 1997;9:291-306 pubmed
  612. Pihlgren M, Dubois P, Tomkowiak M, Sjogren T, Marvel J. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med. 1996;184:2141-51 pubmed
  613. Hattori N, Kawamoto H, Katsura Y. Isolation of the most immature population of murine fetal thymocytes that includes progenitors capable of generating T, B, and myeloid cells. J Exp Med. 1996;184:1901-8 pubmed
  614. Steeber D, Green N, Sato S, Tedder T. Lyphocyte migration in L-selectin-deficient mice. Altered subset migration and aging of the immune system. J Immunol. 1996;157:1096-106 pubmed
  615. Sumita S, Ozaki S, Okazaki T, Sobajima J, Nakao K. A vascular smooth muscle-specific CD4+ T cell line that induces pulmonary vasculitis in MRL-+/+ mice. Clin Exp Immunol. 1996;105:163-8 pubmed
  616. Pear W, Aster J, Scott M, Hasserjian R, Soffer B, Sklar J, et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med. 1996;183:2283-91 pubmed
  617. Locksley R, Reiner S, Hatam F, Littman D, Killeen N. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science. 1993;261:1448-51 pubmed
  618. Mixter P, Russell J, Durie F, Budd R. Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin. J Immunol. 1995;154:2063-74 pubmed
  619. Laouar Y, Ezine S. In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells. J Immunol. 1994;153:3948-55 pubmed
  620. Ledbetter J, Rouse R, Micklem H, Herzenberg L. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med. 1980;152:280-95 pubmed
  621. Diamond M, Staunton D, Marlin S, Springer T. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 1991;65:961-71 pubmed
  622. Vremec D, Zorbas M, Scollay R, Saunders D, Ardavin C, Wu L, et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med. 1992;176:47-58 pubmed
  623. Takahashi K, Nakata M, Tanaka T, Adachi H, Nakauchi H, Yagita H, et al. CD4 and CD8 regulate interleukin 2 responses of T cells. Proc Natl Acad Sci U S A. 1992;89:5557-61 pubmed
  624. Schuyler M, Gott K, Shopp G, Crooks L. CD3+ and CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis. Am Rev Respir Dis. 1992;146:1582-8 pubmed
  625. Ledbetter J, Herzenberg L. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979;47:63-90 pubmed